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1. Introduction  
Since the discovery of first Wnt gene (Wnt-1) in 1982, numerous investigations have focused 
on the roles of different Wnt proteins in regulation of cellular proliferation, differentiation 
and apoptosis in a cell-specific and contextual manner (Rao & Kuhl, 2011). Wnts mainly 
activate intracellular biological processes through one canonical pathway and two well-
characterized non-canonical pathways including Wnt/PCP (planar cell polarity) and 
Wnt/Ca2+. The canonical pathway is also known as Wnt/ǃ-catenin pathway due to the key 
roles of ǃ-catenin in transcriptional regulation of downstream genes. These pathways play 
distinct roles in embryonic development, cell fate determination, cell polarity generation 
and cell movements, cross-talks always occur through a variety of intracellular signal 
molecules. In this chapter, we mainly focus on the up-to-date understanding of canonical 
Wnt signaling, including its functions and regulatory mechanisms both in animal 
development and human diseases. 
2. An overview of canonical Wnt signaling 
In the canonical Wnt signaling pathway, ǃ-catenin is the key downstream effector. With the 
absence of Wnt ligands (Fig. 1, right), cytoplasmic ǃ-catenin is associated with adenomatous 
polyposis coli (APC) and Axin proteins and phosphorylated by glycogen synthase kinase 3ǃ 
(GSK-3ǃ) and casein kinase I (CKI), resulting in its polyubiquitination and protease- mediated 
degradation. Under these conditions, the Lymphoid Enhancer Factor/T-cell factor (LEF/TCF) 
family of transcription factors in the nucleus is able to associate with transcriptional co-
repressors to respress the transcription of Wnt target genes. In the presence of Wnt ligands 
(Fig. 1, left), the binding of a Frizzled (Fz or Fzd) receptor and a low-density lipoprotein 
related receptor protein (LRP5/6) 5 or 6 co-receptor, and the interaction of Fzd with 
cytoplasmic protein Disheveled (Dsh or Dvl) results in the phosphorylation of Dsh/Dvl by 
CKI and binding to GSK-3ǃ with the involvement of Frequently Rearranged in Advanced T-
cell lymphomas (FRAT) protein. These events lead to inactivation of the Axin/APC/GSK-
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3ǃ/CKI complex and thus the inhibition of ǃ-catenin phosphorylation and degradation, 
allowing the translocation and accumulation of cytosolic ǃ-catenin into the nucleus. Nuclear ǃ-
catenin then interacts with LEF/TCF family transcription factors and several other 
transcriptional co-activators to initiate transcription of target genes. 
 
Fig. 1. An overview of Wnt/ǃ-catenin signaling pathway (Modified from Masckauchan & 
Kitajewski, 2006). 
2.1 Components of canonical Wnt signaling 
The canonical Wnt signaling pathway mainly consists of multiple components including 
ligands (Wnts), receptors (Fz and LRP5/6), ǃ-catenin complexes in cytoplasma (GSK-3ǃ/ 
Axin/APC) and nucleus (TCF/LEF), Dsh (Dvls)/Frat protein, and downstream target 
genes. Those elements are highly conserved during evolution in species from fly to 
mammalian. Recent studies have expanded our knowledge of the repertoire of regulatory 
molecules involved in the Wnt signaling pathway, such as Caveolin-1, Norrin, R-spondin, 
sFRP, DKK, SOST/Sclerostin, Arrow, Ror, Krm, Lzts2, and so on.  
2.1.1 The Wnt family 
In general, Wnt genes encode 38- to 43-kDa glycoproteins with features of typical secreted 
growth factors, including a hydrophobic signal peptide, the absence of additional 
transmembrane domains, highly conserved cysteine residues, and the presence of N-linked 
glycosylation sites. Up to now, intensive studies have shown that Wnt genes exist in a wide 
range of species, including Drosophila, Caenorhabditis elegans (C. elegans), Danio rerio, Xenopus, 
mouse and human (Table 1). The Wnt family members are classically divided into canonical 
and non-canonical pathway components depending on their ability to transform C57MG 
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mammary cells or induce axis duplication in Xenopus. The canonical Wnts include Wnt1, Wnt2, 
Wnt2a, Wnt3, Wnt3a, Wnt7a, Wnt7b, Wnt-8a, Wnt10a and Wnt10b while Wnt4, Wnt5a and 
Wnt11 activate the noncanonical Wnt pathways. Generally speaking, the distinction between 
two groups of ligands is as follows: Canonical Wnts bound to Frizzled and activate the ǃ-
catenin/TCF-mediated transcription, whereas non-canonical Wnts bound to Frizzled and 
activate small Rho GTPases, c-Jun N-terminal kinase (Jnk) and other ǃ-catenin-independent 
signaling events. However, an increasing number of recent studies have indicated that the two 
types of Wnts can regulate the canonical and noncanonical pathways each other.  
 
 Wnt proteins Frizzled proteins 
Mouse and 
human 
Wnt1, 2, 2B, 3, 3A, 4, 5A, 5B, 6, 7A7B, 8A, 8B, 
9A, 9B, 10A, 10B, 11, 16 
FZD1–10, Fz, SMO 
X. laevis 
XWnt1, 2, 2B, 3, 3A, 4, 5A, 5B, 6, 7A, 7B, 7C, 8A, 
8B, 10A, 10B, 11, 16 
XFz1-9, 10A, 10B, SMO 
Danio rerio 
Wnt1, 2, 2Bǂ, 3A, 4A, 4B, 5A, 5B, 7Aǂ, 7Bǂ, 8A, 
8B, 9A, 9B,10A,10B, 11,16 
Fz1-6, 7a, 7b, 8a, 8b, 8c, 
9, 10, SMO 
C. elegans CWN-1, 2 and EGL-20 
MOM-5, LIN-17, CFZ-
2, MIG-1 
D. melanogaster Wg, DWntD, DWnt2, 4, 5, 6, 10 Dfz2, Dfz3, Dfz4, SMO 
Table 1. Wnt and Frizzled proteins in mammals (mouse and human), D. melanogaster,  
X. laevis, Danio rerio (zebrafish) and C. elegans. Fz/Dfz, Fz in D. melanogaster; XFz, Fz in  
X. laevis; MOM-5, more of mesoderm (MS) family member-5; LIN-17, abnormal cell Lineage 
family member-17; CFZ-2, C. elegans Frizzled homolog family member-2; MIG-1, abnormal 
cell migration family member-1. For more details, see (van Amerongen & Nusse, 2009; 
http://www.stanford.edu/ ~rnusse/Wntgenes/zebraf Wnt.html) 
2.1.2 Receptors 
Both canonical and noncanonical classes of Wnt ligands transduce signals through 
membrane receptors including FZD1-10, LRP5, LRP6, ROR1, ROR2 and RYK. 
2.1.2.1 Frizzled (Fz, FZD) family 
The Fz family consists of seven-pass transmembrane proteins that are similar to G protein-
coupled receptors. Fz exist in Drosophila, C. elegans, Danio rerio, Xenopus, mouse and human 
(Table 1). Fz exhibit a number of typical features (Huang & Klein 2004): (i) a highly 
conserved cysteine-rich domain (CRD), which may constitute the orthosteric binding site for 
Wnts; (ii) a linker region that shows little sequence similarity among family members; (iii) a 
highly conserved seven- transmembrane domain; and (iv) a cytoplasmic domain of variable 
size and little sequence homology among family members. 
2.1.2.2 LRP5/6 co-receptor and Arrow 
The LRP5/6, additional single-pass transmembrane proteins, is low-density lipoprotein 
receptor-related protein 5/6. Drosophila Arrow is homologous to mouse LRP5 and LRP6. 
LRP5 and 6 contain three ligand-binding repeats, four ǃ-propeller regions and the flanking 
epidermal growth factor (EGF) repeats. The intracellular domain of LRP5/6 can bind to 
Axin. The LRP5/6 interaction domain of Dkk has been mapped to the C-terminal domain. 
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2.1.2.3 Ryk and Ror  
Ryk and Ror, also single transmembrane domain Wnt receptors, are not required for, but in 
some cases may antagonize Wnt/ǃ-catenin signaling. The receptor tyrosine kinases Ror1/2 
(Ror in D. melanogaster; Cam-1, CAN cell migration defective in C. elegans) and Ryk (called 
Derailed in D. melanogaster; Lin-18 in C. elegans) should be seen as autonomous Wnt 
receptors, Fzd coreceptors, or possibly both (Schulte, 2010). 
2.1.3 β-catenin complex 
2.1.3.1 β-catenin 
ǃ-catenin is an essential transcriptional co-activator in the canonical Wnt pathway and exists 
as an unstable monomer in the cytoplasm. Cytoplasmic ǃ-catenin (not binging to Wnts) is 
rapidly turned over through the action of multi-component protein phosphorylation 
machinery consisting of GSK-3ǃ, Axin, and APC protein (formed GSK-3ǃ/Axin/APC 
complex). Phosphorylated ǃ-catenin is targeted for degradation by proteosome. The binding 
of Wnts to their receptors results in the nuclear translocation and accumulation of ǃ-catenin 
and thus activation of LEF/TCF transcription factors by formation of the LEF/TCF complex 
to initiate the expression of target genes. ǃ-catenin homolog in Drosophila is called 
Armadillo. The Armadillo and ǃ-catenin consist of 13 Armadilllo (Arm) repeat domains, 
which are essential for interaction with other proteins. Vertebrates have two Armadillo/ǃ-
catenin homologs, ǃ-catenin and plakoglobin (also called gamma-catenin).  
2.1.3.2 GSK-3β/Axin/APC complex 
GSK-3 was first identified as a consequence of its phosphorylation activity toward glycogen 
synthase. The mammalian GSK3 contains two members GSK-3ǂ and GSK-3ǃ. GSK-3ǃ, also 
known as human tau protein kinase (TPK I), is a multifunctional serine-threonine kinase 
discovered in 1980 and originally identified as a regulator of glycogen metabolism. 
Phosphorylation of the tyrosine 216 residue results in the constitutive activity of GSK-3ǃ, 
suggesting this residue is important for signal transduction. GSK-3ǃ contains three groups 
of binding sites: ATP site, Axin binding site and Priming site.  
There are two vertebrate Axin genes. Axin1 is constutively expressed, but Axin2 (also called 
Conductin or Axil) is induced by activation of Wnt signaling and therefore functions in a 
negative feedback loop. Several functional domains in Axin have been mapped, including 
an RGS-box (or RGS domain) for the Axin and APC interaction, two binding domains for ǃ-
catenin and GSK, and a DIX domain for Axin and Dishevelled interacion. Axin also binds to 
the phosphatase PP2A. 
Both mammals and Drosophila carry two APC genes: APC and APC2 (APCL) in mammals, 
and dAPC1 and dAPC2/E-APC in Drosophila. There is a natural mouse apc1 mutant called 
min1. Mammalian APC contains multiple binding sites for numerous proteins (Aoki & 
Taketo, 2007), including microtubules (a basic domain), ǃ-catenin (15-aa or 20-aa repeats), 
Axin (SAMP repeats), cytoskeletal regulators EB1 and IQGAP1 (C-terminal domains), and 
the Rac guanine-nucleotide-exchange factor (GEF) Asef1 (an armadillo repeat-domain). An 
oligomerization domain is also found at the N-terminal of APC.  
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2.1.3.3 TCF/LEF complex 
In invertebrates, there is one TCF gene rarely displaying alternative transcripts. However, 
vertebrates have four TCF genes (Tcf-1, Lef-1, Tcf-3 and Tcf-4), and each of them gives rise to 
a variety of alternative transcripts (Nusse, 1999; Arce et al, 2006). Four domains are existed 
in an invertebrate TCF: (i) an N-terminal ǃ-catenin-binding domain (BCBD); (ii) a central 
domain; (iii) a well-conserved high-mobility group (HMG) DNA-binding domain, including 
a nuclear localization signal (NLS); and (iv) a long C-terminal tail. The general structures are 
conserved in vertebrate TCF/LEFs: TCF-1E isoforms are remarkably similar in overall 
domain structure to invertebrate TCFs; other vertebrate TCF isoforms have lost parts of 
these domains and/or included novel peptide motifs.  
2.1.4 Dishevelled (Dvl/Dsh) 
Three Dsh proteins Dsh-1, Dsh-2, and Dsh-3 have been found in mammals, while only Dsh in 
Drosophila and mig-5 in C.elegans. The Dsh family members in all organisms are comprised of 
three highly conserved domains (Habas & Dawid, 2005): (i) an amino-terminal DIX domain 
(named for Dsh and Axin), which is essential for the interaction between Dsh and Axin; (ii) a 
central PDZ domain (named for Postsynaptic density-95, Discs-large and Zonula occludens-1); 
and (iii) a carboxy-terminal DEP domain (for Dsh, Egl-10 and Pleckstrin).  
2.1.5 Target genes (http://www.stanford.edu) 
The canonical Wnt pathway controls biological processes via the regulation of target gene 
expression, including direct and indirect target genes. The expression of direct Wnt target 
genes, e.g. cyclin D1 and Myc, multidrug transporter P-glycoprotein (MDR1/ABCB1), is 
activated by the transcription factor TCF, which binds to specific sequence motifs in the 
promoter. Indirect target genes are regulated via transcription regulators, which are also 
targets of the Wnt pathway. Wnt signaling can promote the expression of several Wnt 
pathway components, including Fz, LRP5/6, DKK, Axin, Tcf, Lef and so on. The results 
indicate that feedback controls are key features of Wnt signaling regulation. 
2.1.6 Other factors 
1. ǃ-arrestin 
ǃ-arrestins are originally identified as negative regulators of G protein-coupled receptors 
(GPCR). ǃ-arrestin-1 and -2 are required for cellular communication by means of Wnts and 
FZDs. In canonical pathway, ǃ-arrestins participate in the formation of a ternary complex 
composed of phosphorylated Dvl, ǃ-arrestin and Axin, and affect the transcriptional activity 
of TCF/LEF (Schulte et al, 2010). It is not clear whether ǃ-arrestin serves only as a 
scaffolding protein or whether ǃ-arrestin-dependent endocytosis is required. 
2. CKI  
The CKI family is highly conserved monomeric serine–threonine protein kinases. 
Mammalian contain several CKI isoforms, which are ǂ, ǃ, Ǆ, ǅ and ǆ. CKI prefer substrates 
primed by prior phosphorylation and works closely with other kinases in the Wnt pathway 
(Cheong & Virshup, 2011): First, CKI is itself regulated by posttranslational modification 
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including autophosphorylation; Second, CKI plays a role in phosphorylation of Dvl in the 
Wnt signaling pathway; Finally, CKI also regulate the Wnt signaling pathway by interacting 
with the Wnt receptor LRP. 
2.2 The regulatory mechanism of canonical Wnt signaling  
The regulatory mechanisms of canonical Wnt signaling pathway are very complicated. It is 
well established that components of Wnt/ǃ-catenin pathway include Wnts, Fz, LRP5/6, APC, 
Axin, Dvl, GSk3ǃ, CKI, TCF/LEF and so on. These components can form different complex 
and play distinct regulatory roles in canonical Wnt signaling: some components exert their 
roles as activators, such as canonical Wnts, Dvl, while some components act as inhibitors, such 
as GSK-3ǃ. The canonical Wnt pathway can be regulated by other molecules such as R-
spondins, Dkk, Wise, Caveolin-1, Neucrin, sFRP, and Wif and this pathway also can crosstalk 
with multiple signaling pathways including BMP, TGF-ǃ, Notch, FGF signaling, and so on. 
2.2.1 Activators of canonical Wnt signaling pathway 
Many signal molecules can activate the canonical Wnt signaling pathway, leading to 
stabilization of ǃ-catenin (Nusse, 1999; Bejsovec, 2005; http://www.stanford.edu/group/ 
nusselab/cgi-bin/Wnt/activators_detectors). Approaches to activate this pathway include: 
(i) increased expression of Wnt ligands, receptors, ǃ-catenin and Axin; (ii) phosphorylation 
of Dvl and LRP tail; (iii) inhibition of GSK-3ǃ activity by factors such as LiCl and Akt; (iv) 
blocking the negative regulators of Wnt signaling, such as Axin and APC; (v) increased 
expression of Dsh (Dvls) to inhibit the function of the degradation complex and 
phosphorylation of ǃ-catenin through its binding to GSK-3ǃ and then promote the target 
gene transcription. Some other activators are described below. 
1. Norrin  
Norrin serves as a ligand and binds to FZD4 to activate the Wnt signaling pathway 
dependenting on the presence of cell surface LRP5. The CRD of FZD4 has been shown to 
play a critical role in Norrin-FZD4 binding and is associated with canonical Wnt signaling.  
2. R-spondins  
R-spondins are a family of cysteine-rich secreted proteins and consist of four homologs 
(Rspo-1, 2, 3, and 4) in vertebrates. No representative is found in C elegans, D. melanogaster, 
or Saccharomyces cerevisiae. All R-spondins contain two furin-like cysteine-rich domains at 
the N-terminus followed by a thrombospondin domain and a basic charged C-terminal tail. 
The furin domain of R-spondins is sufficient to synergize with Wnt3a and antagonize DKK1 
function. Similar to the activity of Wnts, R-spondins activate Wnt/ǃ-catenin signaling 
through binding to LRP6, inducing its phosphorylation, and promoting ǃ-catenin 
stabilization. However, R-spondins do not directly activate LRP6 and require the presence 
of Wnts to block Dkk-induced endocytosis of LRP6 and thus ensure an appropriate receptor 
density in the membrane for Wnt signaling. Although all four R-spondins activate the 
canonical Wnt pathway, R-spondin-2 and -3 are more potent than R-spondin1, whereas R-
spondin-4 is relatively inactive. In addition to LRP6, R-spondin-2 interacts with FZD8 to 
activate the canonical Wnt signaling (Kim et al, 2008). 
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3. CBP (CREB–binding protein) and P300 
CBP or its closely related homolog p300, contains multiple functional domains including 
CREB binding domain, Bromo-domain, three zinc finger, Gluarrine-rich domain and HAT. 
Despite the high degree of homology, CBP and p300 are not completely redundant and have 
unique critical roles: CBP but not p300 is essential for hematopoietic stem cell self-renewal, 
whereas p300 is critical for proper hematopoietic differentiation (Teo & Kahn, 2010). The C-
terminal domain of ǃ-catenin has been found to interact with the histone acetyltransferases 
CBP/p300, which have distinct functions in the regulation of TCF/ǃ-catenin–mediated 
survivin/BIRC5 transcription. ICG-001, a selective CBP/Catenin Antagonist, can modulate 
the canonical Wnt Signaling.  
4. Ubiquitin ligase RNF146 (RING finger protein 146) 
RNF146 is a RING-domain E3 ubiquitin ligase. RNF146 can act as a positive regulator of 
Wnt signaling through ubiquitylating and destabilizing Axin and tankyrase (Callow et al, 
2011).  
5. C/EBPǃ, Shikonin and Testosterone 
CCAAT/enhancer binding protein ǃ (C/EBPǃ) is rapidly induced in early stages of 
adipogenesis and is responsible for transcriptional induction of Peroxisome proliferator- 
activated receptor Ǆ (PPARǄ) and C/EBPǂ by maintaining active Wnt/ǃ-catenin signaling, 
after addition of adipogenic inducers. C/EBPǃ is involved in the expression of Wnt10b, a 
major Wnt ligand in preadipocytes, while C/EBPǃ is not an essential factor for the 
regulation of Wnt10b expression during adipogenesis. 
Shikonin is a natural naphthoquinone compound and inhibits adipogenesis through the 
activation of the Wnt/ǃ-catenin pathway. Shikonin induces the upregulation and nuclear 
translocation of ǃ-catenin. 
Testosterone supplementation in men decreases fat mass. Testosterone and 
dihydrotestosterone inhibit adipocyte differentiation in vitro through an AR-mediated 
nuclear translocation of -catenin and activation of downstream Wnt signaling. 
6. Frat protein/GBP 
Three homologs (Frat1, Frat2 and Frat3) are found in vertebrates. The Frat homolog is called 
GBP in Xenopus, which is essential for embryonic axis formation. No protein similar to 
FRAT/GBP has been found in Drosophila. Frat proteins are potent activators of canonical 
Wnt-signal transduction: First, the binding of Frat to GSK3 can induce signaling through -
catenin/TCF; Second, Frat can bind to Dishevelled and advocate as the "missing link" that 
bridges signaling from Dishevelled to GSK3 in the canonical Wnt pathway. 
2.2.2 Antagonists of canonical Wnt signaling pathway  
2.2.2.1 Antagonists that bind to Wnt ligands 
When antagonists bind to Wnt, they prevent Wnts from binding their receptors and 
presumably block the activity of Wnt signaling pathway. Antagonists in this group include 
sFRP, WIF-1 and Cerberus (Rubin et al, 2006). 
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1. Soluble Frizzled-related proteins (sFRPs) 
The sFRPs family consists of a group of Wnt binding proteins including a frizzled-type 
cysteine-rich domain (CRD). Unlike the Frizzled, the C-terminus of sFRPs contains a netrin 
(NTR) domain and has no transmembrane segments. The sFRPs are encoded by FRP/FrzB 
genes, including sFRP1-2, FrzB, sFRP4-5 and Sizzled. sFRP1 and sFRP2 are identified to 
antagonize the Wnt activity. FrzB interacts with Wnt-8 and block the Wnt-8 signaling in 
Xenopus embryos development. In mammalian cells, FrzB can bind to Wnt1 and inhibit the 
ǃ-catenin accumulation induced by Wnt1.  
2. Wnt inhibitory factor-1 (WIF-1) 
WIF-1 is a unique Wnt antagonist with differences in structure from sFRP and Dkk families. 
WIF-1 contains a highly conserved N-terminal domain named WIF domain (WD) and five 
epidermal growth factor repeats  and the WD domain is sufficient for Wnt binding and 
signaling inhibition.  
3. Cerberus 
Cerberus belongs to the Cerberus/Dan gene family and lacks the FZD-CRD and WD. The 
identified members of Cerberus include mouse cerberus-like gene (mCer-1) and cerberus-
like-2 (mCer2), chick Cerberus (ccer), Xenopus Cerberus (Xcer) and Coco, zebrafish Charon. 
However, the mCer-1 does not encode a Wnt antagonist and the antagonist activity of 
mammalian Coco has not been confirmed. 
4. Wingful (Wf)/Notum 
Notum, formerly called Wf in Drosophila, is a secreted hydrolase and has orthologs in mice 
and human. A number of studies have shown that Notum can also regulate Wnt signaling. 
For example, overexpression of Drosophila Wf severely inhibits Wg signaling activity and 
serves as a potent feedback inhibitor of Wg and complements the embryonic Naked cuticle 
(Nkd) system. In addition, Notum is a novel target of ǃ-catenin/TCF4 and high levels of 
Notum are significantly associated with intracellular (nuclear or cytoplasmic) accumulation 
of ǃ-catenin protein. 
2.2.2.2 Antagonists that bind to LRP5/6 
1. Dickkopfs (DKK) family 
DKKs were the first glycoproteins reported to block the -catenin pathway by binding to 
LRP5/6 and disrupting the formation of LRP5/6–FZD complexes. DKKs include DKK1–4 
(no counterpart in D. melanogaster) and the DKK-like protein 1 (Dkk-3-related protein which 
is named Soggy in D. melanogaster). There are two conserved cysteine-rich domains (Cys-1 
and Cys-2) in DKKs, while Sgy lacks cysteine-rich domains. 
DKK-1 and DKK-4 display a Wnt antagonist mechanism, while the mechanism for the 
antagonizing effect of DKK-1 or -4 on LRP6 and Wnt/ǃ-catenin pathway remains unclear. 
Results from several studies indicate that the Cys-2 domain of DKK-1 binds to LRP6 and 
Krm, forming a ternary complex and inducing LRP6 internalization. However, another 
reseach group has reported that DKK-1 blocks Wnt signaling but does not promote LRP6 
internalization and degradation. The mechanism for DKK-2 activity is also disputable. Two 
groups have reported that DKK-2 is a poor inhibitor of Wnt signaling similar to DKK-1, 
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while another group has found the Wnt antagonizing activity of Dkk-2. There are two 
possible explanations for this discrepancy: (i) DKK-2 binds to LRP6 with a lower affinity and 
the binding Kd value is approximately 2 folds of that for DKK-1 (0.73 nM vs 0.34 nM); (ii) 
Dkk-2 is suggested to play the role as an agonist in low-Wnt/high-LRP6 condition, and acts 
as an antagonist in environment with high-Wnt levels. DKK-3 does not bind to LRPs or 
Krm1/2 and can not inhibit Wnt signaling. 
2. Neucrin  
Neucrin consists of a cysteine-rich domain in its carboxyl terminal region, similar to two 
domains of DKKs. Neucrin as well as DKKs bind to LRP6 and inhibit the stabilization of 
cytosolic -catenin, indicating that Neucrin is also an antagonist of canonical Wnt 
signaling.  
3. Wise/sclerostin 
Wise (also known as Sostdc1, ectodin and USAG-1) is a member of Dan family of 
glycoproteins including Cerberus, gremlin, Dan, Coco, and protein-related-to-Dan-and -
Cerberus. Recently, Wise and the related protein sclerostin were identified as inhibitors 
since they bind to the extracellular domain of the Wnt co-receptors LRP5 and LRP6. Sost 
shares 36% amino acids identity with Wise. They share a “cysteine knot” domain that 
occupies the central part of proteins. Sost behaves exclusively as an antagonist for 
Wnt/LRP5/6 signaling in mammalian cells and Xenopus embryos, whereas Wise alone can 
function as a weak agonist to activate ǃ-catenin signaling to a limited extent. Unlike DKK1, 
Sost inhibition of Wnt signaling is insensitive to the presence of Krm2, a transmembrane 
protein that binds to DKK1.  
4. CTGF (Connective tissue growth factor) 
CTGF, a CCN family member, is a multi-domain protein and each domain can interact with 
several ligands, such as growth factors (e.g. TGF-ǃ, BMP-4), cell surface proteins (e.g. LRP) 
and extracellular matrix proteins. CTGF can suppress Wnt signaling through binding to 
LRP6. This interaction is likely to occur through the C-terminal domain of CTGF. 
5. SERPINA3K 
SERPINA3K is a member of the serine proteinase inhibitor (SERPIN) family. The interaction 
between SERPINA3K and the extracellular domain of LRP6 blocks the Fz/LRP6 
(receptor/co-receptor) dimerization induced by a Wnt ligand. Reseachers have also found 
that SERPINA3K binds to LRP6 with a Kd of 10 nM.  
6. Adenomatosis polyposis coli down-regulated 1 protein (APCDD1) 
APCDD1 is a membrane-bound glycoprotein that is abundantly expressed in human hair 
follicles. Former studies have found two Tcf-binding motifs in the 5’-flanking region of 
APCDD1 and indicated that APCDD1 is directly regulated by the ǃ-catenin/Tcf4 complex. 
However, recent functional studies show that APCDD1 inhibits Wnt signaling in a cell-
autonomous manner and functions upstream of -catenin. In vitro analysis indicates that 
APCDD1 can interact with Wnt3a and LRP5, two essential components of Wnt signalling. 
These results suggest that APCDD1 is a novel Wnt inhibitor. 
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2.2.2.3 Factors binding to Fz 
1. Shisa 
Homologues of Shisa are found in human, rat and chick, Xenopus and Zebrafish. However, 
no Shisa homologues are identified in Ciona intestinalis, C.elegans or Drosophila. All Shisa 
proteins contain two CRD and an N-terminal signal peptide. Shisa proteins represent a 
distinct family of Wnt antagonists, which trap Fz proteins in the ER and prevent Fz from 
reaching the cell surface. 
2. Other factors 
sFRP and Insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) can also antagonize 
Wnt signaling via binding to both Fz and LRP6 (MacDonald et al, 2009).    
2.2.2.4 Factors binding to β-catenin 
1. Chibby (Cby) 
Cby physically interact with ǃ-catenin and compete with the TCF/LEF family for binding to 
ǃ-catenin. The coiled-coil motif of Cby is responsible for its specific binding to the armadillo 
repeats 10−12 and the C-terminal region of ǃ-catenin. And phosphorylated Cby plays an 
essential role in the intracellular distribution of ǃ-catenin in conjunction with 14-3-3 protein.  
2. ICAT (Inhibitor of ǃ-catenin and TCF4) 
Orthologs of ICAT are highly conserved in vertebrate except frogs. ICAT inhibit ǃ-catenin to 
bind to TCF/LEF and functions as a negative regulator of Wnt signaling. The crystal 
structure data indicate that ICAT bound to the armadillo repeat domain of -catenin, since 
ICAT contains an N-terminal helilical domain that binds to repeats 11 and 12 of -catenin, 
and an extended C-terminal region that binds to repeats 5-10 in a manner similar to that of 
Tcfs and other ǃ-catenin ligands. 
3. Caveolin-1 (Cav-1) 
Cav-1 is an integral membrane proteins and accumulates of ǃ-catenin within caveolae 
membranes and thus inhibits the ǃ-catenin/Lef-1 signaling activated by Wnt-1 or the 
overexpression of ǃ-catenin itself. Recent findings indicate that Cav-1 inhibits Wnt signaling 
by directly interacting with ǃ-catenin depending on its scaffolding domains (Mo et al, 2010).  
4. Lzts2 
Lzts2 previuosly called LAPSER1 is a putative tumor suppressor that can directly interact 
with and mediate the nuclear export of -catenin. We have recently shown that Lzts2 plays 
important roles in the dorsoventral patterning and embryonic cell movements in zebrafish 
(Li et al, 2011). 
2.2.2.5 Factors associated with LEF/TCF 
1. Groucho  
Long Groucho/TLEs are transducin-like-enhancer of Split orthologs that function as the 
inhibitor of canonical Wnt pathway. The ǃ-catenin and LEF/TCFs activation complexes are 
opposed by the LEF/TCFGroucho repressor complexes. The C-terminal WD repeat 
domain in Groucho/TLE is responsible for binding to LEF/TCFs.  
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2. Endostatin 
Endostatin is a C-terminal fragment of collagen XVIII and blocks the canonical Wnt 
mediated transcription depending on TCF.  
2.2.2.6 Dvl inhibitors 
1. Naked cuticle (Nkd) 
The insects typically have a single Nkd gene, whereas there are two Nkd genes, Nkd1 and 
Nkd2, in human, mouse and zebrafish (have additional homology Nkd3). Nkd1 and Nkd2 
contain a most conserved region of the EFX domain in species from fly to vertebrate. The 
EFX domain is required for the interaction of Nkd with the basic/PDZ domains of Dsh or 
Dvl in fly and vertebrate, thus inhibiting Wnt/ǃ–catenin signaling.  
2. Protease-activated receptors (PARs) 
PARs belong to a large family of seven-transmembrane-spanning G protein-coupled 
receptors (GPCRs), which can couple to Gǂi/o, Gǂq, or Gǂ12/13 within the same cell type. 
PAR1-Gǂ13 associations inhibit the canonical Wnt signaling pathway by the recruitment of 
Dvl, an upstream Wnt signaling protein via the DIX domain.  
3. Dapper/Frodo  
Dapper (Dpr) is also called Frodo or Dact. A conserved C-terminal PDZ-binding motif in 
Dpr is responsible for the interaction with the PDZ domain of Dvl. This interaction depends 
on the phosphorylation of Dpr by CKIǅ/ǆ.  
2.2.3 Context-dependent agonists/antagonists 
1. CKI 
CKI family plays a complicated role in Wnt/ǃ-catenin signaling in a context-dependent 
manner: CKIǂ acts as a potent negative regulator of ǃ-catenin for interacting with Axin and 
phosphorylates serine 45 of ǃ-catenin, while CKIǆ and CKIǅ are found to be positive 
regulators and act upstream of Axin and GSK3 to stabilize ǃ-catenin.  
2. sFRPs 
Indeed, biphasic effects of SFRPs were reported: low sFRP1 concentrations promote, 
whereas high sFRP1 concentrations decrease Wingless-induced ǃ-catenin stabilization.     
3. DKK-2  
The N-terminal domains in DKK-1 and DKK-2 have different functions. The N-terminal 
fragment of DKK-2 synergies with LRP6 to induce Wnt signaling activation, while the N-
terminal domain of DKK-1 appears to have no such function. Together with other evidence, 
DKK-2 is suggested to play the role as an agonist in low-Wnt/high-LRP6 condition, and acts 
as an antagonist in environment with high-Wnt levels. 
4. Wise 
It is known that Wise is an inhibitor of canonical Wnt pathway and first identified as its 
ability to alter the antero-posterior characterstic of neuralized Xenopus animal caps by 
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promoting the activity of the Wnt pathway. Thus, Wise appears to have a dual role in 
modulating Wnt pathway. It remains unclear how the Wise interacts with components in 
the Wnt signaling. One explanation is that Wise competes with Wnts for binding to LRP6 in 
the presence of Wnts, Wise and Dkk, and results in a weak Wnt-dependent activity or a 
complete block of receptor activity.  
5. CBP (cAMP response-element binding protein)/P300 
CBP and P300 are bimodal Wnt regulators with conserved roles in organisms from flies to 
vertebrates (Li et al, 2007). CBP/P300 can negatively regulate canonical Wnt signaling 
through directly binding and acetylating TCF, thus reducing TCF ability to bind with ǃ-
catenin. In contrast, CBP acts as a co-activator by directly interacting with the ǃ-cateinin 
(Arm in fly). The interaction domain has been mapped to the N-terminal region of CBP and 
the C-terminal region of ǃ-catenin. A recent study has identified that the phosphorylation of 
a Proline-directed Serine 92 residue modulates the selective binding of CBP with ǃ-catenin. 
2.2.4 Epigenetic regulation  
Epigenetic regulation including DNA methylation of promoter CpG islands and/or histone 
modification often leads to the activation or amplification of aberrant Wnt/ǃ-catenin 
signaling. Many genes endocing components in this pathway can be modified by DNA 
hypermethylation, thus being closely associated with tumorgenesis (Fig.2). In addition,  
 
Fig. 2. Several Epigenetic silencing of regulators contribute to the aberrant activation of 
Wnt/ǃ-catenin signaling in human cancers. Through promoter methylation or histone 
modification, epigenetic silencing of certain nuclear proteins (SOX) and many antagonists 
(SFRP, WIF, Dkk, APC and DACT) disrupt individual levels of the Wnt/ǃ-catenin pathway, 
resulting in constitutive activation of TCF/LEF-ǃ-catenin-dependent transcription of target 
genes. (Ying & Tao, 2009) 
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methylation or histone modification of promoters for some inhibitors including Long 
Groucho/TLEs and Pygopus also affect the activity of canonical Wnt signaling. 
2.2.5 Crosstalk among signaling pathways  
2.2.5.1 Crosstalk with noncanonical Wnt pathway 
There are a number of noncanonical Wnt signaling pathways such as Wnt/PCP, Wnt/Ca2+, 
Wnt/ROR and Wnt/RYK. Among these pathways, Wnt/PCP and Wnt/Ca2+ are well 
characterized and ligands activating the non-canonical pathways mainly include Wnt4, 
Wnt5a and Wnt11. The components of canonical Wnt pathway such as Wnts, ǃ-catenin, Fz 
and Dsh, play roles both in canonical and non-canonical Wnt pathways through distinct 
mechanisms (Grumolato et al, 2010). The molecular mechanisms underlying the interatction 
of two Wnt signaling pathways are shown by a model in Fig.3. The canonical and 
noncanonical Wnts exert reciprocal inhibition at the cell surface by competition for Fzd 
binding: canonical Wnt3a and noncanonical Wnt5a ligands specifically trigger completely 
unrelated endogenous coreceptors LRP5/6 and Ror1/2, respectively through a common 
mechanism that involves their Wnt-dependent coupling to the Frizzled (Fzd) coreceptor and 
recruitment of shared components, including Dvl, Axin and GSK3. 
 
Fig. 3. A model for molecular mechanisms underlying the interatction between canonical 
and noncanonical Wnt signaling. (Details in Grumolato et al, 2010) 
2.2.5.2 TGF-β (Transforming growth factor-β) signaling pathway 
TGF-ǃ signaling pathway includes subfamilies of TGF-ǃ, BMPs, Nodal and activin/inhibin . 
Wnt and BMP pathways cooperate or attenuate each other, thus causing effects that cannot 
be achieved by either alone in many biological events. The componets of Wnt signaling, 
including CK, Wise, sFRPs, are associated with their interaction. For example, the molecular 
mechanisms underlying the interaction between Wnt and BMP signaling are very complex 
(Itasaki & Hoppler, 2010). First, by mutual regulation of each other’s gene expression, 
activation of the Wnt pathway leads to up- or down-regulation of BMP pathway 
components, or vice versa. The second mechanism is, extracellular signaling of both 
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pathways can cause either activation or inhibition of signaling; several secreted molecules, 
including Wise, sFRPs, CK and Cerberus, can bind to extracellular components of both the 
BMP and Wnt pathways. Third, the interactions between signal transduction components of 
the pathways can interfer with or enhance one pathway by signal transduction components 
of the other pathway; the components include Dvl and Smad1 (or Smad3), GSK3 and 
Smad1, ǃ-catenin and Smad, Smad7 and Axin. The forth mechanism is the regulation at the 
promoter or enhancer level.  
2.2.5.3 Crosstalk with Notch signaling 
Notch signaling pathway possesses four different Notch receptors, including Notch1, 2, 3 
and 4. During somite differentiation, the interaction of Wnt and Notch signaling are 
required for activation of the downstream gene cMESO1/mesp2. Notch intracellular domain 
(Notch ICD or NICD) can directly or indirectly interact with several Wnt components 
including Dvl, ǃ-catenin, APC, Axin and GSK-3ǃ, thus controlling the activity of Wnt 
signaling (Andersson et al, 2011). Furthermore, the crosstalk is also seen between sFRPs and 
Notch signaling. The sFRPs bind to ADAM10, downregulating its activity and thus 
inhibiting Notch signaling. 
2.2.5.4 Crosstalk with FGF signaling pathway 
FGFs (22 members) signal enter into the nucleus by binding to FGFR (fgfr1-4) and activate 
multiple signal transduction pathways. There are several models of Wnt-FGF signaling 
interactions. Canonical Wnt pathway can meidiate the expression of FGF16, FGF18 and 
FGF20 genes as well as the regulation of SPRY4 gene transcription. Within the 5'-promoter 
region of human SPRY4 gene, double TCF/LEF binding sites were identified. FGF signaling 
also can affect Wnt signaling. For example, the activation of Wnt pathway by FGF-2 is 
mediated by PI3K/Akt signaling to maintain undifferentiated hESC. In addition, Wnt 
componets, including ǃ-catenin, GSK-3, Axin, antagonist of Wise, are associated with the 
interaction between canonical Wnt and FGF pathways. 
2.2.5.5 Crosstalk with TNF (Tumor necrosis factor) signaling pathway  
TNF is a cytokine involved in systemic inflammation and is a member of cytokines that 
stimulate the acute phase reaction. The cooperation of Wnt and TNF signaling pathways 
play important roles in the regulation of many biological events. Early signals induced by 
TNF- via the death domain of TNFR1 are required for the mediation of downstream effects 
on ǃ-catenin/TCF4 activity and for TNF--induced antiadipogenesis. A recent study has 
indicated TNF- enhances the Wnt/ǃ-catenin signaling by induction of Msx2 expression. In 
addition, TNF signaling regulated by Wnt pathway is essential for tooth organogenesis.  
2.2.5.6 Crosstalk with Hedgehog (Hh) signaling 
The vertebrate Hh family is represented by at least three members: Desert Hh (Dhh), Indian 
Hh (Ihh) and Sonic Hh (Shh). The Hh pathway is able to interact with canonical Wnt 
pathway. Hh signaling inhibits the canonical Wnt signaling and proliferation in intestinal 
epithelial cells meidiated by Hh repressor Gli1. However, different mechanisms are found in 
the development of spinal cord: dorsal Gli3 expression might be directly regulated by 
canonical Wnt activity; In turn, Gli3, by acting as a transcriptional repressor (mediated by 
TCf), restrictes graded Shh/Gli ventral activity to properly pattern the spinal cord. 
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Although Shh is an inhibitor of the Wnt/ǃ-catenin pathway, activation of Wnt/ǃ-catenin 
signaling upregulates Shh expression during normal development of fungiform papillae. 
Thus, the positive and negative feedback loop that coordinates Wnt and Shh pathways is 
essential for fungiform papillae development. Recent findings indicate that Shh is a 
downstream target of Wnt signaling and acts as a negative-feedback regulator of Wnt 
signaling via Dkk1 and other targets.  
2.2.5.7 Crosstalk with retinoic acid (RA) signaling 
RA is a lipophilic molecule and a metabolite of vitamin-A (all-trans-retinol). Most of studies 
have suggested that RA can inhibit canonical Wnt signaling pathway. For example, the RA 
activity in the perioptic mesenchyme is required for expression of Pitx2 and Dkk2, which 
affects Wnt/ǃ-catenin signaling during eye development. Retinoic acid can downregulate 
the expression of Wnt-3a in mouse development and repress the expression of Wnt8a and 
Wnt3a in the developing trunk. Depending on the presence of RA or not, recent findings 
suggest a dual activity for RA interaction with Wnt signaling: RARǄ regulates Wnt/ǃ-
catenin signaling in chondrocytes positively or negatively depending on retinoid ligand 
availability. RARǄ enhances the Wnt/ǃ-catenin signaling under retinoid-free conditions, but 
inhibits the signaling in RA-treated cells.  
3. Roles of canonical Wnt signaling in animal development 
Canonical Wnt signaling is a highly conserved pathway involved in a variety of biological 
processes for animal development and homeostasis. Here, we mainly focus on three aspects: 
(i) Its roles in the embryogenesis, especially the establishment of Spemann organizer and the 
patterning of body axes. (ii) Its roles in the regulation of mammalian stem cell fate and 
somatic cell reprogramming. (iii) Its roles in the development of organs, such as nervous 
system, cardiovascular system, reproductive system, digestive system and skeletal system.  
3.1 Invertebrate development  
3.1.1 Drosophila development 
In the Drosophila embryo, wg is required for formation of parasegment boundaries and for 
maintenance of engrailed (en) expression in adjacent cells (Wodarz & Nusse, 1998). Embryos 
with mutations in genes porcupine (porc), dsh, armadillo (arm) and pangolin (pan), exhibit a 
very similar phenotype. By contrast, mutations in zeste-white 3 (zw3) demonstrate an 
opposite phenotype, a naked cuticle.  
3.1.2 C.elegans development 
In the C. elegans embryo, molecular analysis of three mutants revealed that they encode proteins 
similar to porc (mom-1), mom-2, and frizzled (fz), a Wnt receptor (mom-5). Similar to the pan 
mutant, mutation of pop-1, an HMG box protein results in an opposite effect of mom mutations: 
both EMS daughters adopt the E fate and produce exclusively gut (Wodarz & Nusse, 1998).  
3.1.3 Cnidarians development 
Wnt signaling is also essential for cnidarian embryogenesis (Guder et al, 2006). Recent 
works have revealed that almost all bilaterian Wnt gene subfamilies (except Wnt9) are 
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present in cnidarians. An additional Wnt (WntA) is present in cnidarians. Therefore, the 
hydroid and sea anemone are used to discuss the roles of canonical Wnt signaling in 
cnidarians development. The important example is that the formation of Hydra head 
organizer is known to be activated by Wnts. HyWnt3a is expressed in a small cluster of 
ectodermal and endodermal epithelial cells at the apical tip of the hypostome and at the site 
of the head organizer. HyTcf is expressed in the hypostome, but in a broader domain than 
Wnt3a and shows a graded distribution highest at the apex. HyDsh and hyGsk-3 are 
uniformly expressed throughout the polyp at low levels, although hyGsk-3 transcripts are 
absent in the foot region cells. The hypostome have much higher levels of nuclear ǃ-catenin 
than cells in the body column, indicating that Wnt signaling is active in the hypostome. 
3.2 Vertebrate development 
3.2.1 Embryogenesis  
The role of Wnt/ǃ-catenin signaling during embryogenesis has been well characterized in 
Xenopus, zebrafish and mouse. 
3.2.1.1 The fate of Xenopus body axis  
In Xenopus, the canonical Wnt signaling acting through ǃ-catenin functions both in 
establishing the dorsoventral axis and in patterning the anterior–posterior axis. During early 
cleavage, preferential localization of maternal ǃ-catenin to nuclei of cells on the future dorsal 
side of the embryo establishes the dorso-ventral axis. However, this nuclear localization of 
ǃ-catenin, which sends a transient dorsal signal to neighboring cells, disappears briefly 
about the time the blastopore begins to form. While several maternally expressed Wnts 
(XWnt-5a, XWnt-7b, XWnt-8b, XWnt-11) are not required for this dorsal ǃ-catenin signal. The 
dorsalizing activity of Wnt ligands, however, is lost at or shortly after the midblastula 
transition (MBT) around 7–8 h of development. Soon afterward, during gastrulation, Wnt 
signaling is thought to play roles in nervous system patterning and notochord-somite 
boundary formation, and perhaps in suppressing dorsal axis formation on the ventral side. 
The components of canonical Wnt pathway play different roles in the body axis formation of 
Xenopus. In embryos, ectopic expression of Wnts such as Wnt1 or Wnt8a, can induce the 
formation of a secondary body axis. However, XWnt-3a plays a major role in anterior– 
posterior patterning of the neuroectoderm and mesoderm. The ǃ-catenin is required for axis 
formation and enriched dorsally by the two-cell stage in a manner dependent on cortical 
rotation. XTcf-3 is required for early Wnt signaling to establish the dorsal embryonic axis 
and closely related Xlef-1 is required for Wnt signaling to pattern the mesoderm after the 
onset of zygotic transcription. A number of studies have indicated that CKII has a critical 
role in the establishment of the dorsal embryonic axis. Dvl has been shown recently to be 
enriched dorsally in one-cell embryos, and ectopic GFP-tagged Dvl is transported along the 
microtubule array during cortical rotation. The activity of GSK-3 plays dual roles in Xenopus 
axis formation depending on its distribution and association with two GSK-3 binding 
proteins, GBP and Axin.  
3.2.1.2 The development of zebrafish body axes 
In zebrafish, maternally Wnt/ǃ-catenin signaling is essential for the formation of organizer 
(also known as ‘‘shield’’). The zygotic Wnt/ǃ-catenin signaling is activated by Wnt ligands 
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after MBT to antagonize the organizer and be involved in anterior-posterior patterning of 
the neural axis. In the zebrafish embryo, ǃ-catenin accumulates specifically in nuclei of 
dorsal margin blastomeres at as early as the 128-cell stage. This asymmetric nuclear 
localization of ǃ-catenin is an early marker of the dorsoventral axis. Soon after the MBT, ǃ-
catenin activates the expression of a number of zygotic genes, including bozozok, chordin, 
Dkk1, squint (sqt) and FGF signals. These ǃ-catenin targets act to inhibit the action of 
ventralizing factors or, in the case of Sqt, induce mesendodermal fates at the dorsal margin. 
However, genetic studies in zebrafish have shown that Wnt8 signals are essential for the 
establishment of ventral and posterior fates. During gastrulation, Wnt8 mRNA and strong 
activity of a Wnt/ǃ-catenin responsive reporter are evident at the ventrolateral margin. 
Simultaneous reduction of Wnt3a and Wnt8 activities results in a stronger expansion of 
dorsoanterior fates, indicating that these two Wnts have overlapping functions. Wnt 
inhibitors, such as Cerberus, Frzb1 and Dkk1, can function as head inducers. The Wnt 
antagonist Dkk1 is expressed early in the dorsal margin and dorsal yolk syncytial layer and 
during gastrulation in the developing prechordal plate, where it could function to 
counteract the ventralizing and posteriorizing effects of canonical Wnt signaling. Another 
Wnt antagonist Caveolin-1 (Cav-1) can maternally regulate dorsoventral patterning by 
limiting nuclear translocation of active ǃ-catenin in zebrafish (Mo et al, 2010).  
3.2.1.3 The fate of mouse body axis 
Wnt/ǃ-catenin signaling also plays multiple roles in the production and patterning of the 
mouse primary axes similar to that in frog and fish. The Wnt/ǃ-catenin signaling precedes 
primitive streak formation and is present in epiblast cells that will go on to form the 
primitive streak. The N-terminally nonphosphorylated form of ǃ-catenin as well as Wnt/ǃ-
catenin signaling is first detectable in the extraembryonic visceral endoderm in day-5.5 
embryos. Before the initiation of gastrulation at day 6.0, Wnt/ǃ-catenin signaling is 
asymmetrically distributed within the epiblast and is localized to a small group of cells 
adjacent to the embryonic–extraembryonic junction. At day 6.5 and onward, Wnt/ǃ-catenin 
signaling was detected in the primitive streak and mature node. The expression of Wnt3, 
high levels of ǃ-catenin and TCF-responsive promoter activity are detected at the site of 
primitive streak formation in the embryo posterior; conversely, the Wnt inhibitor Dkk1 was 
expressed in anterior visceral endoderm. Extensive studies have indicated that Wnt3 and β-
catenin knockout mice fail to form the primitive streak, whereas knockout of the Wnt 
inhibitor Dkk1 results in an anterior truncation. In this way, the role for Wnt in early head-
tail development within the mouse embryo could be viewed as similar to that for A-P 
patterning in frogs (Marikawa, 2006). In the mouse embryo, Axin is a maternal protein 
present throughout development and Axin mutations lead to axis duplication, similar to the 
effects of ectopic Wnt8 expression. 
3.2.2 Embryonic stem cell (ESC) 
Canonical Wnt signaling has been implicated in the control of various types of stem cells 
and may act as a niche factor to maintain stem cells in a self-renewing state. The stem cells 
contain tissue-specific somatic stem cells, tumor (or cancer) stem cells and ESC (Reya & 
Clevers, 2005; Nusse, 2008; Valkenburg et al, 2011), and the details of the former two types 
of stem cells are showed in Section 3.2.3 and 4.1, respectively. Mammalian ESCs provides an 
excellent model system for studying cell fate determination in early development of mouse 
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and human. Studies have shown that activation of Wnt/ǃ-catenin signaling in human and 
mouse ES cells enhance the expression of pluripotency genes and may facilitate the self-
renewal of stem cells. For example, in ESCs, overexpression of Wnt1 or stabilized ǃ-catenin 
or lack of APC results in the inhibition of neural differentiation and in the activation of 
downstream targets of Wnt signaling, including cyclins and c-myc.  
Most of Wnt signaling components are involved in the control of ESC differentiation. For 
example, ESCs cultured in Wnt3a-conditioned medium undergo mesendoderm 
differentiation. Under the condition of elevated ǃ-catenin activity, cultured mouse ESCs at 
high density embark on neural differentiation. Inhibition of GSK-3ǃ transiently enhances the 
maintenance of ESCs. In addition, in mouse ESCs, loss of Tcf3 function promotes self-
renewal in the absence of leukemia inhibitory factor (LIF), but these cells cannot form 
embryoid bodies. Canonical Wnt/ǃ-catenin signal is reported to regulate nuclear orphan 
receptor Nr5a2 (also known as liver receptor homologue-1, Lrh-1) expression. ǃ-catenin and 
Tcf3 are targeted to Nr5a2 and Nr5a2 and in turn directly activate the expression of Tbx3, 
Nanog, and Oct3⁄4, which are components of the core pluripotency network. Based on these 
findings, a model has been proposed for the effects of canonical Wnt signaling pathway on 
the ESCs (Tanaka et al, 2011). Moreover, an elevated level of Wnt signaling activity can 
promote the maintenance of pluripotency, but the normal level of Wnt⁄ ǃ-catenin signaling 
has no apparent impact on ESCs. 
Reseaches identified Wnt ligands expressed in human ESCs or pluripotent stem cells. For 
instance, Wnt3, 5a and 10b mRNAs are expressed in undifferentiated human ES cells; Wnt5a 
and 8b mRNAs in embryoid body; Wnt6, 8b and 10b mRNAs in ESC-derived endoderm 
precursor cells; Wnt4, 5a, 6, 7a, 7b and 10a mRNAs in ES cells-derived neural precursor cells. 
The expression patterns of Wnt ligands indicate that canonical Wnt signaling plays 
important roles in maintenance and differentiation of human ESCs.  However, it appears 
that roles of Wnt signaling in the maintenance and differentiation of human and mouse 
ESCs are controversial. For example, human ESCs cannot be maintained by 
supplementation of Wnt3a in the absence of feeder cells, raising the possibility that feeder 
cells produce factors that synergize with Wnt signals to support the self-renewal of ESCs.  
3.2.3 Organogenesis and development 
Single molecules in canonical Wnt pathway are important regulators in animal development 
and implicated in tissue homeostasis of adult organisms. In adult animals, there are tissue-
specific somatic stem cells (SCs) niches in adults have been found in mesenchymal, 
hematopoietic, neural, epidermal and gastrointestinal tissues. It is well known that many 
signaling pathways and their signaling networks, including Wnt, FGF, Notch, Hedgehog, 
and TGFǃ/BMP, are essential for animal development. In this section, we mainly discuss 
the roles and molecular mechanisms of canonical Wnt pathway in the control of animal 
organgenesis and in the fate determination of somatic stem cells.  
3.2.3.1 Cardiovascular system development  
1. Cardiomyocytes differentiation 
The Wnt/ǃ-catenin signaling is essential for cardiac differentiation (Cohen et al, 2008). 
Canonical signaling through Wnt1 and Wnt3a expression in the anterior mesoderm inhibits 
www.intechopen.com
 
Regulation of Canonical Wnt Signaling During Development and Diseases 
 
85 
the expression of early cardiac genes in the cardiac crescent of chick and frog embryos, 
including Nkx2.5 and GATA4. However, conditional deletion of ǃ-catenin1 by cytokeratin 
19 (Krt19)-Cre results in formation of ectopic heart tissues in the endoderm, suggesting that 
downregulation of ǃ-catenin activity promotes cardiac differentiation. Although lots of 
Wnts are expressed during cardiac specification of mouse embryo, but their molecular 
mechanism remains unclear. It has been shown that a bi-phasic regulation of Wnt/ǃ-catenin 
signaling is existed in mouse cardiac differentiation: activation of Wnt/ǃ-catenin signaling 
pathway in the early phase; inhibition of this pathway and activation of the noncanonical 
pathway in later phases. The biphasic role for this pathway is also found in zebrafish cardiac 
differentiation. However, Wnt11, a non-canonical Wnt signaling ligand that can activate the 
caspase 3⁄8 to degrade ǃ-catenin and thereby inhibits canonical Wnt signaling, is required at 
later stages of cardiac differentiation. These data suggest that Wnt/ǃ-catenin signaling 
mainly plays a suppressive role in the cardiogenesis.  
2. Vascular development and remodeling 
Wnt/ǃ-catenin signaling has been shown to play important roles in vascular development 
and remodeling (Tian et al, 2010; van de Schans et al, 2008). Loss of ǃ-catenin also leads to 
defective endocardial cushion/cardiac valve development through defective endothelial- 
mesenchymal transformation. Several Wnt ligands, such as Wnt2a, Fzd5, have been 
implicated in regulating EC development and associated with abnormal placental vascular 
development. Inhibition of canonical Wnt signaling often results in decreased vascular 
smooth muscle cells (VSMCs) proliferation and cyclin D1 expression.  
3.2.3.2 Hematopoietic system development 
1. Hematopoiesis 
Hematopoietic stem cells (HSCs) have the ability to generate all lineages of blood cells, 
including red blood cells, platelets, lymphocytes, monocytes, and macrophages. Wnt2b is a 
key factor for hematopoietic stem or progenitor cells. Purified Wnt3a proteins promote the 
self-renewal of HSCs derived from Bcl2-transgenic mice. Therefore, the self-renewal of 
HSCs is likely promoted by the canonical Wnt signaling activation and Wnt signals can 
provide signals for HSC fate determination in the stem cell niche (Staal & Luis, 2010). 
However, some studies have shown that constitutive activation of ǃ-catenin impairs 
multilineage differentiation and causes exhaustion of the HSC pool. The controversial 
results may be resulted from: (i) different levels of Wnt/ǃ-catenin signaling activation; (ii) 
dosage responses of Wnt signaling required; (iii) the interference by other signals in the 
context of Wnt activation; and (iiii) Wnt proteins in various blood cell types.  
2. Lymphopoiesis 
The canonical Wnt signaling plays a crucial role in Lymphopoiesis, such as T cell and B cell 
development. The canonical Wnt signaling is aasociated with most immature stages of T cell 
development. Overexpression of cell autonomous inhibitors of ǃ-catenin and Tcf (ICAT) 
blocks the development of earliest stage T cells in the thymus. Similarly, the secreted Wnt 
inhibitor DKK1 can inhibit the thymocyte differentiation at the most immature stages. On 
the contrary, overexpressing activated forms of ǃ-catenin leads to the generation of more 
thymocytes and activates proliferation-associated genes in immature thymocytes. The 
canonical Wnt signaling can regulate B cell development. Lef1-deficient mice have a mild 
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block of B lymphopoiesis in fetal but not in adult, and show defects in B cell proliferation. 
Depletion of Fz9 leds to pronounced splenomegaly, thymic atrophy, and lymphadenopathy 
with age, with accumulation of plasma cells in lymph nodes during mouse development. In 
addition, treatment of human B cell progenitors with Wnt3a in the stromal cell co-culture 
assays negatively regulates the cell proliferation. 
3.2.3.3 Nervous system development 
1. Neural crest stem cells (NCSCs) 
Wnt/ǃ-catenin can induce sensory neurogenesis by acting instructively on embryonic 
neural crest stem cell (NCSCs) (Toledo et al, 2008). In the central nervous system (CNS), the 
activation of ǃ-catenin leads to the amplification of the neural progenitor pool. Constitutive 
expression of ǃ-catenin in neural stem/progenitor cells results in the expansion of the entire 
neural tube. In addition, Wnt ligands, such as Wnt3a, promote the differentiation of neural 
SCs in the neocortex at E11.5 at the expense of neural SC expansion. Continuous 
neurogenesis in adult happens only in two specialized niches of the adult CNS, 
subventricular zone (SVZ) and subgranular zone (SGZ). 
2. Neural crest formation 
Canonical Wnt signaling has been found in early stages of neural crest development, such as 
neural crest induction and melanocyte formation. For example, ablation of ǃ-catenin results 
in a decrease of tissue mass in the spinal cord and brain, and the neuronal precursor 
population, and a lack of melanocytes and sensory neural cells in dorsal root ganglia.  
3. Neuronal differentiation 
Numerous components of canonical Wnt signaling have been shown to regulate the precise 
patternings of developmenting neural tissue. Wnt1 acts as a mid-hindbrain organizer and 
the ablation of Wnt-1 causes severe deficiencies during mid–hindbrain formation in mice; 
Wnt-3, -3a, -7b and -8b, can participate in the development of the forebrain (gives rise to 
hippocampus). The functions of Wnts in neuronal differentiation depend on signals with 
temp-spatial distribution, triggering the differentiation of precursor cells to neurons. 
4. The development of dopaminergic (DA) neurons  
DA precursors can respond to canonical Wnts. For example, before the appearance of DA 
neurons, the expression of Wnt-1 and Wnt-3a is detected in the developing ventral midbrain 
(VM). In addition, the GSK-3ǃ-specific inhibitor kenpaullone increases the DA 
differentiation through stabilizing ǃ-catenin in ventral mesencephalic precursors. There are 
13 Wnt ligands, all 10 Fzds receptors, and several intracellular Wnt signaling modulators are 
identified to developmentally regulate the development of midbrain and the DA precursors 
respond to Wnts in a very specific/temporal manner.  
5. Synapses 
The function of Wnt signaling pathway in synapses has been characterized during neuronal 
development. Wnts play roles in the formation of the sensory–motor connections in mouse 
spinal cord. Wnt-3 and 7a can promote synaptogenesis inducing the clustering of synapsin I, 
a presynaptic protein involved in synapse formation and function. This effect is controlled 
by the canonical pathway and can be mimicked by the GSK-3ǃ inhibition induced by 
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lithium. Interestingly, the Dvl-1 is found to present in synaptosomes of adult mice and it 
also co-localized with the presynaptic markers synaptophysin, bassoon and VAMP-2. 
6. Sympathetic nervous system development 
A recent study has shown that Fz3 acts at early developmental stages to maintain a pool of 
dividing sympathetic precursors, likely via activation of ǃ-catenin, and Fz3 functions at later 
stages to promote innervation of final peripheral targets by post-mitotic sympathetic 
neurons. 
7. Canonical Wnt signaling in brain 
It is known that the expression of specific Wnt ligands occurs in distinct regions of 
developing human brain (Malaterre et al, 2007). The major role of Wnt1 is to regulate the 
proliferation of precursor populations in the developing mid-/hindbrain region; Wnt7b is 
expressed in cerebral cortical and diencephalic progenitor cells during early human 
development; Wnt3a appears to have a very specific role in the development of the 
hippocampus, a structure involved in integrating many of the higher order tasks, such as 
memory and learning. ǃ-catenin in the E9.5 telencephalon is highly enriched at the apical 
end of the neural precursor cells and colocalized with N-cadherin at adherens junctions, 
implying that the main role of ǃ-catenin at this stage of telencephalic specification is to 
promote neuroepithelial adhesion. Other canonical Wnt pathway-related factors are also 
implicated in a number of aspects of brain development. GSK-3ǃ and ǃ-catenin 
transcriptional partners LEF1 and TCF4 are expressed during brain development in mouse. 
These results suggested that brain developent respond to canonica Wnt signaling pathway 
in a very specific and temporal manner.  
3.2.3.4 Reproductive system development  
1. Gonadal development 
Many Wnt genes are expressed in gonads. Wnt1, 3 and 7a are specifically expressed in the 
testis; Wnt5a, Wnt6 and Wnt9a are specifically expressed in the ovary; Wnt4 is expressed in 
mouse gonads in both sexes at embryonic day 9.5 (E9.5) and becomes ovary-specific at the 
time of sex determination around E11.5. These expression patterns of multiple Wnt genes in 
the gonads suggest that canonical Wnt signaling pathway is essential for gonadal 
development. Activation of Wnt/ǃ-catenin signaling is required for female differentiation 
(Liu et al, 2009). Although ǃ-catenin is present in gonads of both sexes, it is necessary for 
ovarian differentiation but dispensable for testis development. Lacking ǃ-catenin, defects in 
ovaries are strikingly similar to those found in the R-spondin1 (Rspo1) and Wnt4 knockout 
mouse ovaries, including formation of testis-specific coelomic vessel, appearance of 
androgen-producing adrenal-like cells and loss of female germ cells. Studie have found that 
activation of ǃ-catenin in otherwise normal XY mice effectively disrupts the male program 
and results in male-to-female sex-reversal. 
The expression of sex determining gene Sry (sex-determining region Y) within the initially 
bipotential gonad is sufficient to induce the male developmental program. Both human 
SRY and mouse Sry are capable of repressing the Rspo1/Wnt/ǃ-catenin signaling, 
thereby switching on testis determination. Interestingly, the HMG box of human SRY can 
bind directly to ǃ-catenin while the mouse Sry binds to ǃ-catenin via its HMG box and 
glutamine-rich domain. 
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2. Mammary stem cells and Mammary gland development 
Several lines of evidence suggest that canonical Wnt signaling is involved in the 
maintenance of the stem/progenitor pool in the mammary gland. The stem/progenitor 
fraction is increased in the hyperplastic mammary glands of MMTV–Wnt-1 and MMTV– 
ΔNǃ-catenin transgenic mice and in primary cultures of mammary epithelial cells treated 
with Wnt-3a. In addition, Lrp5 is expressed in the basal epithelium and cells with high 
expression have a 200-fold greater ability to regenerate a mammary tree when transplanted 
into cleared mammary fatpads. Embryos overexpressing the Wnt antagonist Dkk1, as well 
as animals deficient for Lrp6 or Lef-1, fail to form mammary placodes. These findings 
validate the importance of Wnt/ǃ-catenin in mediating the activity of mammary stem cells. 
The canonical Wnt signaling is essential for specification and morphogenesis of the 
mammary gland. Numerous components of the Wnt signaling cascade are expressed during 
embryonic mammary morphogenesis, including Wnt ligands (i.e., Wnt1, 2, 3, 3a, 5a, 5b, 6, 
7b, 10a, 10b, 11), receptors (i.e., Fzd1-9, LRP5, LRP6), and downstream DNA-binding 
proteins (i.e., Tcf1, 3, and 4 and Lef1). Wnt2, Wnt5a and Wnt7b are enriched in the terminal 
end bud microenvironment. Targeting other positive acting elements of the Wnt pathway, 
such as Lrp6, Lrp5, Lef1 and Pygo2, can result in placodal impairments, ranging from loss to 
reduced size and degeneration, while stimulating ǃ-catenin signaling produces the converse 
effect – acceleration, expansion and induction of placodes and placodal markers. During 
mammary development, Wnt5a is considered to negatively regulate the Wnt/ǃ-catenin 
pathway. Constitutive expression of the canonical Wnt4 leads to more highly branched 
ducts in virgin females, similar to what occurs during early pregnancy. 
3. Prostate stem cells (PSCs) and Prostate gland development 
Evidence of canonical Wnt signaling involvement in prostate stem cells is based on limited 
studies. A few findings suggest that Wnt signaling regulates the terminal differentiation of 
basal cells into luminal cells by controlling the proliferation and/or maintenance of 
epithelial progenitor cells. For example, more p63 (basal cell marker) positivity is seen in the 
ductal region of Wnt3a-treated cultures while fewer p63 positive cells are present in Dkk1-
treated cultures. These results are supported by the CK8 (luminal cell marker) 
immunostaining. The expression of many Wnt signaling molecules such as Fzd6 and Wnt2 
is increased in both fetal and adult PSC. This result means that adult PSCs acquire 
characteristics of self-renewing primitive fetal prostate stem cells, which in turn might also 
be characteristic of oncogenesis.  
The canonical Wnt pathway has been implicated in prostate development (Kharaishvili et al, 
2011). Wnt antagonist sFRP2 is highly expressed early in prostate development and down-
regulated at later time points. It is indicated that both enhancement and reduction of 
canonical Wnt signaling can adversely affect branching morphogenesis in the developing rat 
prostate model. Treated with Wnt3a, rat ventral prostate cultures at postnatal day 2 (P2) 
show blunted and enlarged ductal tips at 7th day, while Dkk-treated prostates exhibit poor 
epithelial branching. The highest level of Axin2 is detected on P2, consistent with a higher 
progenitor cell population; while the level declines over time according to prostate 
maturation when the majority of the epithelial cells are terminally differentiated luminal 
cells. Other Wnts and components including three canonical Wnts (Wnt2, Wnt2b and 
Wnt7b), Fzd2 and 4 and Dvl are also highly expressed on P3 in ventral lobes. Except for 
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Wnt7b, all of them show a high expression at birth with levels declining during and after the 
completion of morphogenesis. Those results suggest that the canonical Wnt signaling is 
temporally regulated during prostate development.  
3.2.3.5 Skeletal development 
1. Mesenchymal stem cells (MSCs) 
The MSCs can differentiate into mesoderm-derived chondrocytes, osteocytes, adipocytes, 
fibroblasts, myocytes as well as nonmesoderm-derived hepatocytes, and neurons. Canonical 
Wnt signals are required for maintenance of undifferentiated MSCs, inhibition of adipocyte 
maturation, dedifferentiation of adipocytes, and inhibition of osteoblastic differentiation 
(Ling et al, 2009). MSCs express a number of Wnt ligands including Wnt2, Wnt4, Wnt5a, 
Wnt11 and Wnt16, and several Wnt receptors including FZD2, 3, 4, 5 and 6, as well as 
various coreceptors and Wnt inhibitors. Exogenous application of Wnt3a to cell cultures 
expands the multipotential population of MSCs by up-regulation of cyclin D1 and c-Myc. 
Moreover, the overexpression of LRP5 can increase proliferation of MSCs. Dkk1 is required 
for the arrested hMSC to re-enter into cell cycle and subsequent proliferation. Interestingly, 
studies have revealed that canonical Wnt signaling stimulates hMSC proliferation at low 
dose while inhibits it at high dose. This dual effect of Wnt signaling suggests the intensity of 
Wnt signals can lead to different or even opposite biological functions. 
2. Cartilage development 
Cartilage development is initiated by chondrogenesis, which requires mesenchymal 
condensation and cartilage nodule formation. A variety of different Wnt signaling 
components positively or negatively regulate different stages of chondrogenesis and 
cartilage development (Chun et al, 2008). Chondrogenesis is inhibited by Wnt-3a via a ǃ-
catenin-dependent mechanism; Wnt-1 and -7a also inhibit chondrogenesis without 
significant effects on early condensation. Chondrocyte maturation and mineralization are 
also blocked or delayed by the forced expression of FrzB, Fzd-1, or Fzd-7. In contrast to the 
inhibition of chondrocyte maturation, constitutively active form of ǃ-catenin promotes 
growth plate chondrocyte terminal differentiation and overexpression of Wnt-8c and -9a in 
chick sternal chondrocytes enhance hypertrophic maturation by upregulating type X 
collagen and Runx2. 
3. Osteoblastogenesis and bone formation 
Canonical Wnt signaling plays an important role in osteoblastogenesis and bone formation. 
Wnt activity in bone marrow varies throughout stages of development and has important 
contributions from several Wnts. Wnt7b is induced during osteoblastogenesis; Wnt10b is 
expressed in bone marrow; Wnt1, 4, and 14 are expressed in calvarial tissue and osteoblast 
cultures; Wnt1 and Wnt3a are induced by BMP2 in a mesenchymal precursor cell line. 
Wnt/ǃ-catenin signaling promotes the bone formation via stimulation of the development 
of osteoblasts. Inhibition of GSK3 enzymatic activity with lithium chloride (LiCl) or small 
molecules (e.g. Chir99021 and LY603281-31-8) stimulates mesenchymal precursors to 
differentiate into osteoblasts. This result is supported by observations with Wnt3a, Wnt1 
and Wnt10b, which activate signaling through ǃ-catenin and stimulate osteoblastogenesis. 
However, Dkk1 can reduce osteoblastogenesis by inhibiting the activity of this pathway. 
Studies suggest that activation of Wnt/ǃ-catenin signaling inhibits adipogenesis of 
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mesenchymal precursors, which may have clinical importance due to the positive 
correlation reported between marrow adipose content and bone fractures.  
3.2.3.6 Eye development 
The canonical Wnt signaling pathway has been shown to be required at multiple points in 
development of the eye, from specification of the eye field to differentiation of the retina and 
determination of retinal polarity (de Iongh et al, 2006). Here, we mainly discuss the 
important roles in the eye development in vertebrates. 
1. Eye specification 
Most of the studies on eye specification have been carried out in Xenopus and zebrafish 
embryos. During zebrafish mid-late gastrulation, canonical Wnts (Wnt1, 8b, 10b and 11) and 
Fzds (Fzd3, 5, 8a) are detected in the anterior neural plate (ANP). Wnt1, 8b and 10b are 
expressed in domains caudal to the eye field (delineated by Rx3, eye marker). Fzd8a 
expression domain overlaps the expression of several anterior neural ectoderm markers 
including Six3, which is expressed in the presumptive eye fields. Fzd5 expression domain 
appears to completely overlap the eye field delineated by Rx3. Zebrafish mutants 
(masterblind and headless) with mutations of axin and tcf3 exhibit defects in eye formation. In 
addition, inhibition of GSK-3 results in eye reduction or loss. Dkk1 induces complete heads 
with two-well formed eyes in larger eyes. Overexpression of Wnt8b or treatment with LiCl 
to activate the canonical Wnt signaling, results in the loss of anterior structures (including 
eyes) and the loss of six3 and rx1 expression. These results indicate that canonical Wnt 
signaling inhibits eye formation. Recent inverstigations suggest that activation of Dkk2 by 
PITX2 can locally suppress the canonical Wnt signaling activity in eye development. 
2. Lens development 
Recent studies have documented the involvement of various components of the Wnt 
signaling pathway in lens morphogenesis and differentiation. Expression of various Wnts 
(Wnt2b, 7a, 7b, 8a, and 8b), Fzd, Dkk and Lef/Tcf, has been identified in the developing eye 
of various species. Expression of these Wnt components is restricted to the lens epithelium 
and down-regulated as cells exit the cell cycle and initiate differentiation into lens fiber cells. 
However, Wnt7b continues to be expressed in the cortical fibers of the lens undergoing 
terminal differentiation. The expression pattern of Wnt components in the lens placode and 
effects of deleting -catenin in the ocular ectoderm indicate that Wnt signals play an 
important role during lens induction and early morphogenesis. Analysis of the Tcf/Lef-LacZ 
mice shows that there is transient activation of Wnt signaling in the anterior lens epithelium 
between E13.5 and E14.5 after closure of the lens vesicle. Several lines of evidence indicate 
that Wnt signals also play key roles in the differentiation of the lens fibers. The active (non-
phosphorylated) form of -catenin and inactivated GSK-3ǃ can be found in lens fiber as well 
as epithelial cells. 
3. Retinal development 
Wnt1, -3, -5a, -5b, -7b and -13 (Wnt2b) are found in embryonic and fetal retinae, and Wnt5a, 
-5b, -10a and –13 in the adult retinal. In the embryonic mouse retina at E12.5, Wnt receptors 
Fzd3, Fzd4, Fzd6 and Fzd7 are expressed throughout the optic cup and Fzd4 is detected in 
the RPE (optic cup, optic stalk). The expression patterns of sfrps are variable during early 
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morphogenesis. The dynamic expression patterns of Wnt, Fzd and Sfrp genes in the 
developing retina suggest the involvement of canonical Wnt signaling pathway.  
3.2.3.7 Liver development  
Canonical Wnt pathway also is essential for liver development (Nejak-Bowen & Monga, 
2008). 15 Wnts and 9 Fzs are identified in an adult mouse liver, and the Wnts expressed in 
various cell types of liver (Table.2). These findings suggest that distinct Wnt signals in 
various cell types might be associated with their different functions. 
 
Cell type of mouse liver Wnt ligands 
Hepatocytes 1, 2, 4, 5a, 5b, 9a, 9b, 11 
Biliary epithelial cells 2, 2b, 3, 4, 5a, 5b, 8b, 9a, 9b, 10a, 10b, 11 
Sinusoidal endothelial cells 2, 2b, 3, 4, 5a, 5b, 8b, 9a, 9b, 10a, 11 
Stellate and Kuffer cells  2, 2b, 3, 4, 5a, 5b, 6, 7a, 8b, 9a, 9b, 10a, 10b,11, 16 
Table 2. Wnt genes expressed in various cell types within liver (Thompson & Monga, 2007).  
In hepatocytes, Active ǃ-catenin is detectable immediately prior to gastrulation at E5.5 in the 
extra- embryonic visceral endoderm and in a narrow region of cells in the epiblast at E6. 
Two associations with ǃ-catenin are important in hepatocytes: One association is the 
connection between ǃ-catenin and E-cadherin at the hepatocyte membrane and the other 
association is that of ǃ-catenin with the hepatocyte growth factor (HGF) and receptor c-Met. 
Several lines of evidence have identified that the regulation of Wnt/ǃ-catenin signaling is a 
requirement for postnatal liver development. It is well known that liver derivation from the 
foregut endoderm occurs around somite stages 5 to 6 as a result of signaling from mesoderm 
in the form of FGFs and BMP4, both of which are incidentally downstream targets of the 
Wnt pathway. Wnt ligands such as Wnt2b, is expressed at these stages and positively 
regulates the induction and specification of zebrafish liver. In mouse, temporal expression of 
ǃ-catenin during mouse prenatal liver development indicates its important role in 
hepatocyte expansion during early liver development (Lade & Monga, 2011). sFRP5 is 
expressed in the ventral foregut endoderm that gives rise to the liver at mouse E8.5 and can 
modulate Wnt activity by delineating borders between organs in the developing gut. 
Canonical Wnt signaling is also important in normal liver growth and regeneration. The 
expression level of ǃ-catenin is increased during postnatal development and can promote 
hepatic growth in mouse. In adult resting liver, the Wnt/ǃ-catenin pathway is quiescent. 
When liver is not being challenged by chemical, metabolic or dietary stress, ǃ-catenin is not 
required for normal physiologic function. However, if liver is injured, proliferation of the 
normally quiescent hepatocytes and cholangiocytes, followed by proliferation of the hepatic 
stellate cells and endothelial cells, quickly restores the liver to its original mass. During this 
regeneration process, levels of ǃ-catenin are dramatically increased in the partial 
hepatectomy (PHx) model. 
3.2.3.8 Kidney development 
A number of Wnt family members are expressed in the mouse embryonic kidney (Merkel et 
al, 2007; Pulkkinen et al, 2008): Wnt-2b, -4, -5b, -6, -7b, -9b and -11 are expressed during 
kidney ontogeny; Wnt-6, -7b, -9b and 11 are expressed in the branching ureteric bud (UB) 
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during the early stages of organogenesis; while Wnt-2b and -4 are detected in the kidney 
mesenchymal cells. In wild type mice, UB-produced Wnt9b is necessary for tubule 
formation, at least in part through its activation of Wnt4 expression in the adjacent 
mesenchyme. However, the precise mechanism for Wnt function in tubule formation 
remains to be defined.  
3.2.3.9 Other organgenesis 
1. Epithelial stem cells 
Epithelial stem cells present in many tissues, including skin, intestine, lung, kidney, and so 
on. The canonical Wnt signaling pathway is shown to play important roles in two leading 
epithelial stem cell models (Gu et al, 2010): the intestine and hair follicle. The canonical Wnt 
signaling is required for the normal homeostasis of epithelial stem cells. Depletion of TCF4 
or overexpression of Wnt inhibitor Dkk1 in intestinal stem cells (ISCs) results in a dramatic 
reduction in proliferation of crypt cells. Inhibition of the Wnt pathway by conditional 
ablation of ǃ-catenin or by ectopic expression of Dkk1 specifically in epithelia, blocks hair 
follicle formation during embryogenesis and causes a loss of the postnatal HFSC niche. 
Conversely, constitutive activation of Wnt pathway results in massive proliferation of 
epithelial stem/progenitor cells.  
2. Lung development 
Canonical Wnt signaling is known to regulate epithelial and mesenchymal cell biology in an 
autocrine and paracrine fashion (Pongracz & Stockley, 2006). Several Wnt ligands, receptors, 
and components of the canonical pathway are expressed in a highly cell-specific fashion in 
the developing lung. For instance, Wnt2 is highly expressed in the distal mesenchyme, 
whereas Wnt7b is expressed predominantly in the epithelium. However, transgenic deletion 
of Wnt2 does not result in any detectable defects of lung development and function, 
probably due to functional redundancy of Wnt2 proteins. ǃ-catenin-dependent signaling is 
central to the formation of the peripheral airways of the lungs and responsible for 
conducting gas exchange, but is dispensable for the formation of the proximal airways. 
Apart from ǃ-catenin and Wnts, mRNA of Fz-1, -2 and -7 and several intracellular signaling 
molecules including Tcf-1, -3, -4, Lef1, and secreted Fz related proteins (sFRP-1, -2 and -4) 
have been found to be expressed in the developing lung in specific and spatio-temporal 
patterns. The canonical Wnt signaling appears to be able to fulfill their roles in maintenance 
of adult lung structure: the components of canonical Wnt pathway such as Wnt-3, -4, -5a, -
7a, -7b, -10b, and -11 as well as Fz-3, -6 and -7, Dvl, and Dkk are expressed in primary lung 
tissue and cell lines derived from adult lung tissue.  
3. Intestinal development  
Intestinal crypts constitute a niche in which epithelial progenitors replicate and prepare to 
differentiate in response to Wnt signals. After appearance of villi, canonical Wnt signaling 
was first detected. However, intervillus cells lacking signs of canonical Wnt signaling 
proliferate actively during villus morphogenesis. In late gestation and briefly thereafter, 
conspicuous Wnt activity is evident in differentiated, postmitotic villus epithelium. 
Further investigations indicate that neither Tcf4 nor candidate Wnt targets CD44 and 
cyclinD1 are expressed in late fetal villus cells with a high Wnt activity. Instead, these 
cells express the related factor Tcf3 and a different Wnt target, c-Myc. Premature and 
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downregulated ǃ-catenin activity can cause severe villus dysmorphogenesis in transgenic 
mice. Lrp5 and Lrp6 are recently found to play redundant roles in intestinal epithelium 
development and might regulate intestinal stem/precursor cell maintenance by 
regulating the canonical Wnt signaling.  
4. Pancreatic development 
Previous studies have demonstrated the importance of canonical Wnt signaling in 
pancreatic development (Wells et al, 2007). The expression of Wnt1 under control of the 
pdx-1 promoter is associated with murine pancreatic agenesis. Other components of Wnt 
pathway are detectable during pancreatic organogenesis, including Wnt2, 2b, 3, 4, 5a, 5b, 7a, 
7b, 14 and 15. All of ten Fzs proteins are found to express in pancreas, with the strongest 
expression of Fz1, 2, 4, 5, and 6 and colocalized expression of Frz 1-7 in the islets of 
Langerhans. Dkk 1, 3, and 4 as well as sFRP 1, 4, and 5 are expressed in the exocrine fraction, 
while sFRP 2 and 3 are detectable at low levels. The effects of ǃ-catenin on mouse pancreatic 
development show somewhat conflicting findings (Murtaugh, 2008). The loss of ǃ-
catenin/Wnt signaling in the developing mouse results in transient pancreatitis, but 
exocrine pancreas has eventually recovered. In addition, a significant role of the Wnt 
pathway in endocrine lineage development using ǃ-catenin knockout mice is identified. 
However, other studies indicate that ǃ-catenin/Wnt signaling is essential for development 
of exocrine pancreas, but plays no role in endocrine development. Therefore, mechanisms 
underlying the regulation of pancreatic development by canonical Wnt signaling require 
further investigations. 
5. Hair follicle and skin development 
The hair follicle is an appendant miniorgan of skin. Canonical Wnt signals play an 
important role in hair follicle development. ǃ-catenin inhibition or Dkk1 overexpression 
specifically blocks hair follicle formation during embryogenesis, and the former results in a 
loss of the postnatal hair follicle stem cells (HFSC) niche. Wnt10b may promote hair-follicle 
growth by inducing the switch from telogen to anagen. Several Wnts such as Wnt4, 10a and 
10b, are expressed in the skin. Alteration of the levels and timing of LEF-1 expression during 
skin embryogenesis in transgenic mice disrupts the positioning and orientation of hair 
follicles, confirming a central role for LEF-1 in hair patterning and morphogenesis. Wnt3 or 
Dvl2 overexpression in transgenic mouse skin causes a short-hair phenotype owing to 
altered differentiation of hair shaft precursor cells and hair shaft structural defects.  
3.3 Reprogramming  
Reprogramming of nuclei allows the dedifferentiation of differentiated cells. Cell-cell fusion 
is a way to force the fate of a cell, and in the case of fusion with ESCs, this mechanism 
induces cellular reprogramming, that is, dedifferentiation of somatic cells. For example, 
ESCs treated for 24 hours with Wnt3a or with the GSK3 inhibitor, 6-bromoindirubin-30- 
oxime (BIO), can reprogram somatic cells after polyethylene glycol (PEG)-mediated fusion. 
Recent studies demonstrate that fusion-mediated reprograming of a somatic cell is greatly 
enhanced by dose-dependent activation of the Wnt/ǃ-catenin signaling pathway. ESCs 
expressing whatever amount of ǃ-catenin can fuse, but normally the fate of the resulting 
hybrids is to undergo apoptosis, unless low levels of nuclear ǃ-catenin allow them to 
undergo reprogramming instead (Lluis et al, 2010). Further studies using genetic knockout 
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ESC models suggest that the canonical Wnt signaling pathway play important roles in 
reprogramming. It is known that the maintainance of mouse ESC (mESC) self-renewal 
requires the growth factor leukemia inhibitory factor (LIF), which stimulates two parallel 
pathways: Stat3/Klf4/Sox2 and PI3K/Tbx3/Nanog. In mouse ESCs, ǃ-catenin promotes 
pluripotency gene expression, including Oct4, Nanog and Tbx3, depending on the 
regulation of Lrh-1.  
4. Canonical Wnt signaling in human diseases  
Abnormal expression of components in canonical Wnt signaling pathway is often associated 
with human diseases including almost of all human cancers (Fig.4). In addition to ǃ-catenin, 
APC, GSK-3ǃ, and Caveolin-1 are considered as key molecules in oncogenic cellular 
transformation, hyperplasia and metastasis owing their abilities to modulate many signaling 
pathways in tumor cells. Some components of this pathway such as ǃ-catenin and Caveolin-
1 are also nvolved in tumor multi-drug resistance (MDR). Additionally, the abnormal 
activity of canonical Wnt signaling has been shown to function in the development and 
progression of cardiovascular diseases, fibrosis, regeneration, wound healing, obesity, 
schizophrenia, osteoarthritis (OA) and diabetes.     
4.1 The activity of canonical Wnt pathway in cancers and therapy  
4.1.1 Tumorigenesis and cancer stem cells (CSCs)  
Genetic predisposition, environmental factor, and aging are risk factors of human cancers. 
Dysregulation of canonical Wnt signaling always results in development of various tumors 
(Fig.4). Down-regulated canonical Wnt signaling inhibitors caused by epigenetic silencing 
and genetic alteration often cause the carcinogenesis, such as colon cancer, prostate cancer 
and Esophageal Squamous Cell Carcinoma.  
Cancer stem cells (CSCs) are closely associated with tumorgenesis. CSCs are characterized 
by their tumorigenic properties, the ability to self-renew and formation of differentiated 
progeny. Similar to normal stem cells, CSCs express some specific surface markers (CD133, 
CD44 and others). CSCs contain many of active signaling pathways that are found in normal 
stem cells, such as Wnt, Notch, and Hedgehog (Hh). A number of studies have 
demonstrated that the Wnt/ǃ-catenin pathway is crucial in the maintenance of CSCs from 
lung, leukemia, breast, melanoma, colon, liver and cutaneous cancers. 
4.1.1.1 Colorectal cancer and intestinal cancer stem cells (ICSCs)  
1. Colorectal cancer (CRC) 
The majority of CRC is caused by mutations in key components of the canonical Wnt 
signaling pathway. In colon cancer, nearly 90% of these tumors harbor mutations that result 
in ǃ-catenin mutation. Germline loss-of-function mutations in the APC gene were originally 
identified to be associated with familial adenomatous polyposis (FAP), about 1% of which 
progress to CRC. Furthermore, 85% of cases of sporadic intestinal neoplasia have mutations 
in APC, while activating mutations in ǃ-catenin are found in approximately 50% of CRC 
tumors lacking APC mutations. Recently, investigatons suggest that ǃ-catenin stabilization 
and C-terminal binding protein 1 (CtBP1) following APC inactivation contribute to 
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adenoma initiation as the first step, and that KRAS activation and ǃ-catenin nuclear 
localization act synergistically to promote adenoma progression to carcinoma. The promoter 
of sFRPs is often hypermethylated in CRCs, suggesting that reintroduction of sFRP can 
reverse the Wnt signaling in CRCs. Moreover, when DACT3 (a member of the Dpr/Frodo 
family) expression is restored by the inhibition of histone methylation and deacetylation, the 
Wnt signaling is ihhibited and CRC cell apoptosis is induced. 
 
Fig. 4. Canonical Wnt signaling and dysregulation in cancers.The Wnt signaling pathway is 
comprised of extracellular, cytoplasmic and nuclear signaling events that are amenable to 
therapeutic intervention. Dysregulation at these stages are common in numerous cancers, 
captured in the white boxes. (Curtin & Lorenzi, 2010) 
2. Intestinal cancer stem cells (ICSCs) 
Extensive researches have been performed to find out which cell type is required for the 
cancer-initiating mutation. A critical work has shown that APC inactivation in Lgr5-positive 
stem cells at the crypt bottom leads to transformation within days. In contrast, APC 
inactivation in progenitors or differentiated cells does not cause tumor formation even after 
30 weeks. These studies indicate that the cellular origin of CRC initiation might be within 
normal stem cells of the intestine, rather than progenitors or differentiated cells. Another 
study has demonstrated that severe polyposis in Apc loss-of-function mutant (Apc1322T) 
mice is associated with increased expression of the stem cell marker Lgr5 and other stem cell 
markers (Musashi1, Bmi1, and the Wnt target CD44). Furthermore, the Wnt target gene 
CD44 has been identified as a marker for colorectal cancer stem cells, and deletion of CD44 
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in APCMin/+ (heterozygous APC) mice attenuates intestinal tumorigenesis. Overall, these 
studies support a cancer stem cell model that Wnt signaling plays a key role in the 
regression of intestinal tumorigenesis. 
4.1.1.2 Breast cancer and cancer stem cells (BCSCs)  
1. Breast cancer 
Studies in both mouse models and human breast cancers have revealed that canonical Wnt 
signaling is critical to mammary tumorigenesis. The mouse mammary tumor virus (MMTV) 
is found to integrate into the Int-1 (Wnt1) locus and overexpression of Wnt1 induces 
mammary tumorigenesis. In human breast cancer, numerous reports have identified that the 
canonical Wnt pathway is dysregulated. Aberrant ǃ-catenin expression is associated with 
basal and triple-negative breast cancers and poor clinical outcome. In addition, 
overexpression of Lrp5 correlates with basal breast cancers. Down-regulation of the sFRPs is 
observed in breast cancers. Although strong evidence has shown the dysregulation of Wnt 
pathway in human breast cancer, there are conflicting studies that fail to find an association 
of this pathway with metastasis or clinical outcome.  
2. Breast cancer stem cells (BCSCs)  
Studies in breast cancer demonstrate that stem cell populations are more resistant to 
radiation treatment and Wnt/ǃ-catenin signaling mediates the resistance. These CSCs 
populations exhibit altered DNA repair in response to radiation and increased AKT (a 
serine-threonine protein kinase) and ǃ-catenin activities. Blocking the AKT and ǃ-catenin 
activation by inhibitor perifosine sensitizes the cells to radiation. These studies have 
underscored the importance of Wnt signaling in breast cancer and the targets for effective 
therapeutics.  
4.1.1.3 Canonical Wnt signaling in prostate cancer and cancer stem cells (PCSCs)  
1. Prostate cancer 
Canonical Wnt pathway has been widely studied in prostate cancer (Kharaishvili et al, 
2011). Wnt ligands are up-regulated in prostate cancer, and their expression often correlates 
with aggressiveness and metastasis. It is shown that elevated levels of Wnt1, Wnt5a, Wnt7b, 
and Wnt11 are closely associated with prostate cancer aggressiveness. In addition, Dkk1 
expression increases during prostate cancer initiation but decreases during metastasis. Other 
Wnt pathway members such as Fz4 and Wif1 are found to be dysregulated in prostate 
cancer.Furthermore, in many cases of prostate cancer, APC is mutated and hypermethylated 
to a silent form and ǃ-catenin is frequently mutated to an active form.  
2. Prostate cancer stem cells (PCSCs) 
Several lines of evidence have identified that Wnt signaling can induce prostate cancer 
initiation, EMT and metastasis, suggesting that canonical Wnts may play a role in the 
regulation of PCSCs (Bisson et al, 2009). Treatment of PCSCs with Wnt inhibitors can reduce 
prostasphere size and self-renewal. In contrast, the addition of Wnt3a causes increased 
prostasphere size and self-renewal. This process is associated with a significant increase in 
nuclear ǃ-catenin, CD133 and CD44 expression. Moreover, Wnt3a treatment increases the 
self-renewal of putative PCSCs independent of androgen signaling.  
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4.1.1.4 Hepatocellular tumors and liver cancer stem cells 
1. Hepatoblastoma  
Hepatoblastoma is the most common malignant liver tumor. Nuclear and cytoplasmic 
localization of ǃ-catenin are reported in 90% to 100% of all hepatoblastomas, familial and 
sporadic due to mutations in APC, CTNNB1, Axin1 and Axin2.  
2. Hyperplasia and hepatic Adenoma, Hepatocellular carcinoma (HCC) 
The Wnt/ǃ-catenin pathway has been examined in several rare benign liver neoplasms and 
the analysis demonstrates that abnormal cytoplasmic or nuclear localization of ǃ-catenin in 
30% of hepatic adenomas from patients. A more recent analysis indicates mutation of ǃ-
catenin in only 12% of adenomas, but 46% of these adenomas progressed to HCC. This 
finding suggests that development of aberrant activity in the Wnt/ǃ-catenin pathway is an 
important step toward progression to HCC.  
The Wnt/ǃ-catenin pathway is also an important player in the progression of hepatic 
adenoma and HCC. Studies have found that 20% to 90% of HCCs display activated ǃ-
catenin because of diverse mechanisms including mutation in genes encoding for CTNNB1, 
Axin-1 and Axin-2, as well as fz7 upregulation and GSK-3ǃ inactivation. However, the status 
of Wnts in HCC remains to be examined. Liver-specific deletion of APC can induce ǃ-
catenin stabilization and increased HCC. In addition, transgenic mouse models 
overexpressing c-myc or TGF-ǃ result in mutation and/or nuclear translocation of ǃ-catenin 
in liver tumors. Interestingly, simultaneous mutation of ǃ-catenin and H-ras leads to 100% 
incidence of HCC in mice. These findings suggest that ǃ-catenin activation is likely an 
initiating or contributory factor in a significant subset of HCCs. Several studies have shown 
that dyregulations of ǃ-catenin in HCC are associated with hepatitis virus, such as hepatitis 
B virus (HBV) and hepatitis C virus (HCV). In addition, mutations in the Axin and Axin2 
genes result in truncated proteins that are detected in about 10% of HCCs.  
It is found that mutations in the ǃ-catenin gene are evident only in a small subset of 
cholangiocarcinomas. Although the role of canonical Wnt signaling in biliary development 
is beginning to be understood, further investigations are needed.  
3. Liver cancer stem cells  
Wnt/ǃ-catenin signaling plays an important role in the maintainance of liver CSCs. For 
example, elevated expression of Wnt and its downstream mediators are shown in EpCAM+ 
liver CSCs. It has been demonstrated that murine hepatic stem/progenitor cells transduced 
with mutant ǃ-catenin can acquire excessive self-renewal capability and tumorigenicity.  
4.1.1.5 Leukaemia and leukemia stem cells (LSCs) 
1. Leukemia stem cells (LSCs) 
Similar to HSCs, LSCs engage in complex bidirectional signals within the hematopoietic 
microenvironment. Two different stages of leukemia progression called “pre-LSCs" and 
established leukemia (LSCs) are identified in a syngeneic retroviral model of MLL-AF9 
induced acute myeloid leukemia (AML). The homing and microlocalization of pre-LSCs is 
most similar to long-term HSCs and dependent on cell-intrinsic Wnt signaling. In contrast, 
the homing of established LSCs is most similar to that of committed myeloid progenitors 
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and distinct from HSCs. In addition, Dkk1 can impair HSC function, while does not affect 
pre-LSCs, LSC homing, or AML development. Moreover, cell-intrinsic Wnt activation is 
observed in human and murine AML samples. For example, Wnt3a can affect the self-
renewal of AML and T-lymphoblastic leukemia (T-ALL) cells. 
2. LSCs associated with AML, CML and MLL 
Acute myelogenous leukemia (AML) is the most common acute leukemia in adults. Only 
small subsets of AML cells (called LSCs) are capable of extensive proliferation and self-
renewal, with several markers similar to HSCs. Recent studies have demonstrated that 
Wnt/ǃ-catenin signaling is required for self-renewal of LSCs derived from either HSC or 
more differentiated granulocyte macrophage progenitors (GMP). As discussed before, the 
Wnt/ǃ-catenin pathway is normally active in HSCs, but not in GMP. In addition, ǃ-catenin 
is not absolutely required for self-renewal of adult HSCs, while ǃ-catenin is required for LSC 
development and maintenance in AML (Wang et al, 2010). Thus, targeting the Wnt/ǃ-
catenin pathway may represent a new therapeutic opportunity in AML. 
A conditional ǃ-catenin knockout model has identified the Wnt/ǃ-catenin pathway as being 
essential for the self-renewal of normal and chronic myelogenous leukemia (CML) stem 
cells:  the impairment of HSC self-renewal in ǃ-catenin-/- mice pre-empted the subversion of 
this property for the generation of CML LSCs (Deshpande & Buske C, 2007).  
Previous studies have found that ǃ-catenin is activated during development of mixed 
lineage leukaemia (MLL) leukemic stem cells (LSCs) (Yeung et al, 2010). Suppression of ǃ-
catenin can reverse LSCs to a pre-LSC-like stage and significantly reduce the growth of 
human MLL leukemic cells. Conditional deletion of ǃ-catenin can completely abolish the 
oncogenic potential of MLL-transformed cells. In addition, established MLL LSCs that have 
acquired resistance against GSK3 inhibitors are resensitized by suppression of ǃ-catenin 
expression. These results unveil previously unrecognized multiple functions of ǃ-catenin in 
the establishment and drug-resistant properties of MLL stem cells, highlighting it as a 
potential therapeutic target for an important subset of AMLs. 
4.1.1.6 Other cancers  
1. Lung cancer  
The canonical Wnt pathway is important for the development of human lung cancer. 
Although increased levels of ǃ-catenin have been reported in different types of lung cancers, 
mutations of APC and ǃ-catenin are rare in lung cancers. Dysregulations of specific Wnt 
molecules (e.g. Wnt1, Wnt2 and Wnt7a) leading to oncogenic signaling are detected in lung 
cancer. Other components of canonical Wnt pathway are found to be associated with lung 
cancer. Overexpression of Dvl has been reported in 75% of non-small cell lung cancer 
samples compared with autologous matched normal lung tissue controls. Downregulation 
of Wnt pathway antagonists like Dkk3, Wif, Caveolin-1 and sFRP have been reported in 
various types of lung cancers. 
2. Esophageal carcinoma 
The roles of canonical Wnt signaling in esophageal carcinoma remain not well understood. 
Some components, including APC, ǃ-catenin, Dkk1 and Caveolin-1, are found to express in 
esophageal carcinoma. The expression of Dkk1 is upregulated on both mRNA and protein 
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levels in esophageal carcinoma tissues compared with the adjacent normal esophageal 
tissues. The positive rates of APC and E-cadherin in esophageal carcinoma are lower than 
those in the normal group and the abnormal expression rates of ǃ-catenin and cyclin D1 in 
esophageal carcinoma are higher than those in the normal group.  
3. Ovarian cancer  
Endometrioid ovarian carcinoma (EOC) frequently exhibit constitutive activation of 
canonical Wnt signaling, usually as a result of oncogenic mutations that stabilize and 
dysregulate the ǃ-catenin protein. For example, the majority of low-grade endometrioid 
ovarian carcinomas often display nuclear immunoreactivity for ǃ-catenin (70% of cases), and 
these cases often harbour mutations in the ǃ-catenin gene at codons for residues 
phosphorylated by GSK-3ǃ (54% of cases). However, high-grade endometrioid ovarian 
carcinomas do not display nuclear ǃ-catenin immunoreactivity and progression is not 
associated with ǃ-catenin mutations. Moreover, nuclear ǃ-catenin in low-grade 
endometrioid EOC is also associated with squamous differentiation and correlates with 
good prognosis and lack of relapse. The EOC also shows constitutive activation of the 
canonical Wnt signaling pathway, usually as a result of oncogenic mutations in the APC and 
Axin tumor suppressor proteins. However, some studies have indicated that mutations in 
Axin are existed in cell lines of endometrioid EOC, while a study from other group has 
found that no mutations in either APC or Axin in human endometrioid EOC. 
Mechanisms for activation of canonical Wnt signaling in ovarian carcinoma exhibit 
histotype dependence. EOC is strongly associated with active mutations in ǃ-catenin. In 
contrast with endometrioid EOC, ovarian carcinomas of serous, clear-cell and mucinous 
histotypes have rarely been associated with activating mutations in the key proteins of the 
Wnt signaling pathway. Recent studies have shown that both GSK-3ǃ and Axin2 are 
overexpressed in serous ovarian cancer. These findings implicate activation of Wnt/ǃ-
catenin signaling in serous EOC in the absence of activating mutations in either APC, Axin 
or ǃ-catenin (Barbolina et al, 2011). 
4.1.2 Potential roles in cancer therapy  
As discussed before, canonical Wnt signaling is active in most of cancers and involed in the 
self-renewal and differentiation of cancer stem cells. Thus, inhibition of Wnt signaling 
activity represents a valuable strategy for cancer therapy. Several classes of drugs targeting 
the Wnt pathway are under development or on the market. These drugs belong to non-
steroidal anti-inflammatory drugs (NSAIDs), vitamin D derivatives, antibody-based 
treatments, small molecule inhibitors, and so on (Table 3).  
4.2 Cardiovascular diseases 
4.2.1 Cardiac hypertrophy 
Cardiomyocytes are terminally differentiated cells existing in heart and the abnormal 
increase in their individual sizes often leads cardiac hypertrophy. The canonical Wnt 
signaling pathway has been found to induce physiological and pathological hypertrophies. 
Cardiomyocyte-specific overexpression of GSK-3ǃ in transgenic mice negatively regulates 
physiologic concentric hypertrophy (normal growth) of ventricular cardiomyocytes, leading 
to a smaller heart with depressed contractility. In addition, Fz2 expression is upregulated 
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during hypertrophic development in the rat heart. Using the model of mice lacking the Dvl-
1 gene, an attenuated hypertrophic response upon pressure overload induced by aortic 
constriction, an increased GSK-3ǃ and Akt activities and reduced ǃ-catenin protein levels 
are observed in these mice. Moreover, it is interesting that ǃ-catenin levels are found to be 
relatively high in the embryonic heart compared with the adult heart, whereas in 
hypertrophic hearts an increase in ǃ-catenin content is observed. It is also found that ǃ-
catenin is stabilized by hypertrophic stimuli, and that overexpression of ǃ-catenin can 
induce hypertrophic growth of cardiomyocyte. Cardiomyocyte-specific deletion of ǃ-catenin 
is shown to attenuate the hypertrophic response upon aortic constriction in vivo.  
 
Inhibitors Subcategory Therapeutic Pathway target 
Developme
nt stage 
Small 
molecules 
NSAIDs Aspirin   ǃ-catenin Clinical 
     
Existing 
drugs and 
natural 
compounds 
 Sulindac, ǃ-catenin Clinical 
 Celecoxib TCF Clinical 
    
Vitamins retinoids ǃ-catenin Clinical 
 1ǂ25,-dihydroxy-
VitaminD3  
ǃ-catenin   Clinical 
Polyphenols Querucetin Unknown Preclinical 
 EGCG Unknown Preclinical 
 Curcumin Unknown Preclinical 
 Resveratrol Unknown Phase II 
 DIF GSK-3ǃ Preclinical 
     
Molecular 
targeted 
drugs 
 PNU 74654 ǃ-catenin/TCF Discovery 
 2,4-diamino-
quinazoline 
ǃ-catenin/TCF Preclinical 
 ICG-001-related 
analogs 
CBP Phase I(2010) 
 NSC668036 Dvl Discovery 
 FJ9 Dvl Discovery 
 3289-8625 Dvl Discovery 
 IWR Axin Discovery 
 IWP Porcupine Discovery 
 XAV939 Tankyrase1&2     Discovery 
     
Biologics  Antibodies Wnt proteins Preclinical 
 Recombinant proteins WIF1 and SFRPs Preclinical 
 RNA interference Wnt proteins Preclinical 
Table 3. A summary of various Wnt therapeutics (Curtin & Lorenzi, 2010; Takahashi-Yanaga 
& Kahn, 2010) 
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4.2.2 Heart failure 
In the failing heart, the abnormal expression of sFRPs is identidfied. sFRP3 and 4 are 
elevated in failing ventricles compared to donor hearts, which is not the case for sFRP1 and 
2, and a reduced Wnt/ǃ-catenin signaling is observed. Although these observations have 
indicated the abnormal activity of canonical Wnt signaling is associated with heart failture 
in human, the mechanisms underlying this association remain to be further investigated. 
4.2.3 Myocardial infarction (MI) and infarct healing 
MI is associated with hypertrophy and directly caused by an acute occlusion of a coronary 
artery. Similar to that during hypertrophic development, Fz2 expression is found to be 
gradually upregulated in the first 10 days after myocardial infarction in the rat. The 
upregulation of Wnt-10b and Fzd-1, -2, -5 and -10 and the downregulation of Wnt-7b are 
also observed in the infarct area at 1 week after infarction in the mouse. It is worth noting 
that Fz2 mRNA is detected in the border zone of the infarct area at 1 week after infarction, 
whereas at 2 weeks after MI, the expression is migrated into the centre of the infarct area. 
Dvl, directly downstream of Fz, shows high levels of expression exclusively at 4 days after 
MI and remains upregulated during the first week after MI. The expression patterns of both 
Fz2 and Dvl closely resemble the location of myofibroblasts in the infarct area. These results 
indicate the myofibroblasts are the Fz2 and Dvl expressing cells and may be involved in 
infarct healing. This conclusion is supported by overexpressing FrzA (a homologue of 
sFRP1) to block Wnt signaling. This intervention shows a profound effect on infarct healing: 
the infarct size is reduced by more than 50% at 15 days post-MI and a concomitant 
improvement of cardiac function is observed in the FrzA-overexpressing mice compared to 
wildtype controls. This effect could be attributed to reduced cardiomyocyte apoptosis, 
limiting the scar area. Reduced infarct size and improved function can be induced by 
adenoviral overexpression of ǃ-catenin in the border zone of the infarcted rat heart, 
suggesting an important role of Wnt/ǃ-catenin signaling in infarct healing.  
4.2.4 Aging  
Aging is the main risk factor for cardiovascular diseases, but the molecular mechanisms are 
poorly understood. In human mammary arteries, the expression of Fz4 and several targets 
of Wnt/ǃ-catenin signaling pathway such as the Wnt-inducible secreted protein 1 (WISP1), 
versican, osteopontin (SPP1), insulin-like growth factor binding protein 2 (IGFBP-2), and 
p21, are modified with age, suggesting an activation of the Wnt ⁄ǃ-catenin pathway in the 
aging process. In aging mammary arteries, the increase in ǃ-catenin-activating 
phosphorylation at position Ser675 is found. Wnt3a or Wnt1 treatment of human vascular 
smooth muscle cells (VSMCs) induces -catenin phosphorylation at Ser675 and the 
expression of WISP1, SPP1, and IGFBP-2. These findings suggest that the activation of Wnt 
pathway occurs in aging human mammary artery cells, but fails to induce the proliferation 
of aging vascular cells (Marchand et al, 2011). 
4.2.5 Other vascular diseases 
Canonical Wnt pathway regulates endothelial dysfunction and vascular smooth muscle cell 
(VSMC) proliferation and migration and thereby intimal thickening. Moreover, the pathway 
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has the capacity to regulate inflammation and foam cell formation, pathological 
angiogenesis and calcification, which are crucial processes in plaque formation and stability. 
Furthermore, it is apparent that altered expression of a handful of Wnt pathway proteins 
occurs in or regulates atherogenesis. All of those findings indicate that canonical Wnt 
pathway acts as an important regulator of vascular diseases, such as atherosclerosis, 
coronary artery disease and hypertension (van de Schans et al, 2008; Tsaousi et al, 2011). 
4.3 Nervous system diseases  
4.3.1 Neural tube defects (NTD) 
Various components of the Wnt signaling pathway have been implicated in NTD. For 
example, Dvl2 null mutants have thoracic spina bifida, and Dvl1/2 double mutants produce 
even more severe NTD. Mutations of axin, a Wnt pathway inhibitor, can result in 
incomplete closure of the neural tube or malformation of the head folds. Alterations 
(hypoactivity, hyperactivity and missense mutations) to LRP6 can cause NTD. 
4.3.2 Primitive neuroectodermal tumors (PNETS) 
Activation of canonical Wnt pathway can lead to PNETS. In some cerebellar and cerebral 
PNETS, mutations that lead to nuclear accumulation of ǃ-catenin are present. Interestingly, 
stabilized ǃ-catenin is not sufficient to cause the development of brain tumors, while 
stabilized ǃ-catenin together with forced expression of c-Myc, a downstream target of the 
Wnt signaling pathway, can lead to increased tumors. 
4.3.3 Alzheimer's disease (AD) 
Alzheimer's disease (AD) is a neurodegenerative disorder associated with aging and 
characterized by fibrillar deposits of Aǃ in subcortical brain regions. The main 
proteinaceous component of the amyloid deposited in AD is the amyloid-ǃ-peptide (Aǃ 
peptide), a 40- to 42-residue peptide that has been isolated from senile plaque cores. As 
discussed before, canonical Wnt signaling pathway is involved in neural induction and 
patterning during nervous system development. Thus, abnormal activity of this pathway is 
associated with neurodegenerative disorders, such as AD. Apparently, Aǃ can bind with the 
extracellular cysteine-rich domain (CRD) of the Fz to inhibit Wnt/ǃ-catenin signaling. 
Studies have indicated the exposure of rat hippocampal neurons to Aǃ results in three 
hallmarks related with Wnt signaling: (i) destabilization of endogenous levels of ǃ-catenin; 
(ii) an increase in GSK-3ǃ activity; and (iii) a decrease in Wnt target gene transcription. In 
fact, relationship between Aǃ-induced neurotoxicity and a decrease in the cytoplasmic levels 
of ǃ-catenin has been observed. Inhibition of GSK-3ǃ by lithium is shown to protect rat 
hippocampal neurons from Aǃ-induced damage. Moreover, the conditioned media 
containing Wnt-3a and Wnt-7a are able to overcome the neurotoxic consequences induced 
by Aǃ. In addition, LRP5/6 is also associated with AD.  
4.3.4 Parkinson's disease (PD) 
Parkinson's disease (PD) is caused by degeneration of the dopaminergic (DA) neurons of the 
substantia nigra. The canonical Wnt signaling has a role in promoting adult DA 
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neurogenesis (Inestrosa & Arenas, 2009). Parkin, an E3 ubiquitin ligase linked to familial PD, 
can directly interact with ǃ-catenin and regulates ǃ-catenin levels in vivo. The stabilization of 
ǃ-catenin in differentiated primary ventral midbrain neurons results in increased levels of 
cyclin E and proliferation, followed by increased levels of cleaved PARP and loss of DA 
neurons. In addition, Wnt3a signaling also causes death of post-mitotic DA neurons in 
parkin null animals, suggesting that both increased stabilization and decreased degradation 
of ǃ-catenin can result in DA cell death. 
4.3.5 Schizophrenia  
Schizophrenia is a psychiatric disorder characterized by “positive” symptoms such as 
delusions, hallucinations, and disorganized speech and “negative” symptoms such as lack 
of emotional affect and motivation. The canonical Wnt signaling pathway is a candidate for 
dysregulating brain development, which cause neuroanatomical defects associated with 
schizophrenia (Okerlund & Cheyette, 2011). Studies have shown that Wnt1 is upregulated in 
schizophrenic brains, and some genes associated with susceptibility to the disease are core 
components of the Wnt signaling pathway, such as TCF4, Dkk proteins (especially Dkk1 
and Dkk3), GSK-3ǃ, Fz3, sFRP1 and Dvl3. Taken together, the genetic and pharmacological 
data suggest a potential connection between canonical Wnt signaling and the pathogenesis 
and therapeutics of schizophrenia.  
4.4 Polycystic kidney disease 
Cystic kidney disease is the most common genetic cause of end-stage renal failure. These 
diseases are characterized by the progressive development of cysts in the nephron and 
collecting ducts, and patients often require dialysis and kidney transplantation. One class 
cystic kidney disease is polycystic kidney disease (PKD), which contains two types of 
autosomal dominant (ADPKD) and autosomal recessive PKD (ARPKD). ADPKD typically 
arises during adulthood, whereas ARPKD arises during childhood and is much more 
severe. A second class of cystic nephropathy is characterized as glomerulocystic kidney 
disease, including medullary cystic kidney disease (MCKD) and nephronophthisis (NPHP). 
NPHP is inherited in a recessive fashion and like ARPKD. Two genes have been identified 
for the development of ADPKD: polycystic kidney disease gene 1 (PKD1) and PKD2 that 
encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. However, 11 candidate 
genes are identified in the NPHP and NPHP-like disorders.  
The canonical Wnt signaling is suggested to affect the cystogenesis. For example, the C-
terminus of PC1 can facilitate the nuclear accumulation of ǃ-catenin and the downstream 
transcription is decreased by overexpression of the C-terminus in vitro. In kidney, PC1 
expression is increased in cystic epithelium of patients with PKD. Cysts arise in animal 
models of PKD with complete or partial loss of protein (as in, Pkd1-/-, Pkd1+/- and 
hypomorphic mice) and with overexpression of PC1 protein, suggesting the kidney is 
especially sensitive to gene dosage. These studies indicate that PC1 expression seems to be 
tightly regulated in the kidney, and canonical Wnt signaling might also require similar fine 
tuning. Other canonical Wnt components are also associated with cystic renal disease. For 
example, APC inactivation leads to cystic renal phenotypes in mice. Further evidence for a 
role of canonical Wnt signaling in renal cyst disease comes from work with NPHP animal 
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models. Nphp2 and Nphp3 both negatively regulate the canonical Wnt cascade through 
regulation of Dvl, both in vitro and in vivo in Xenopus laevis embryos. Canonical Wnt activity 
is also affected in a mammalian model of NPHP: knockout mice for Ahi1, a gene mutated in 
the ciliopathy Joubert syndrome (JS), have decreased the canonical Wnt signaling in the 
kidney compared to wild-type mice.  
4.5 Fibrosis 
4.5.1 Kidney fibrosis 
The Wnt/ǃ-catenin signaling is involved in the pathogenesis of renal fibrosis (He et al, 
2009). It has been identified that the majority of 19 different Wnts and 10 frizzled receptor 
genes are expressed at various levels in the normal mouse kidney. All members of the Wnt 
family except Wnt5b, Wnt8b, and Wnt9b are upregulated in the fibrotic kidney with distinct 
dynamics after unilateral ureteral obstruction. In addition, the expression of most Fzd 
receptors and Wnt antagonists is also induced. Furthermore, obstructive injury leads to a 
dramatic accumulation of ǃ-catenin in the cytoplasm and nuclei of renal tubular epithelial 
cells, indicating activation of the canonical Wnt signaling. Numerous Wnt/ǃ-catenin target 
genes (c-Myc, Twist, lymphoid enhancer-binding factor 1, and fibronectin) are also induced 
and their expression is closely correlated with renal ǃ-catenin abundance. Wnt antagonist 
Dkk1 can inhibit myofibroblast activation, suppress expression of fibroblast-specific protein 
1, type I collagen, and fibronectin, and reduce total collagen content in the model of 
obstructive nephropathy. In summary, these results suggest that Wnt/ǃ-catenin signaling is 
involved in the promotion of renal fibrosis. 
4.5.2 Lung fibrosis 
The canonical Wnt signaling pathway is associated with pulmonary fibrosis based on 
studies in animal models and human diseases. Idiopathic pulmonary fibrosis (IPF) is the 
most common form of lung fibrosis. Studies have revealed the overexpression of Wnt genes, 
including Wnt-2 and -5a, the receptors Fz7 and -10, and Wnt regulators, such as sFRP1 and -
2, in IPF lungs compared with normal lungs or those with other interstitial lung diseases. In 
addition, several Wnt target genes, such as matrix metalloproteinase 7, osteopontin, or 
Wnt1-inducible signaling protein (WISP) 1, are recently identified in experimental and 
idiopathic lung fibrosis. Furthermore, the nuclear localization of ǃ-catenin is found in 
alveolar epithelial type II (ATII) cells and interstitial fibroblasts in IPF lungs. These results 
suggest the existence of an activated canonical Wnt signaling in IPF. Morover, abnormal 
activities of other canonical Wnt signaling components, such as GSK-3ǃ, are observed in 
ATII cells. The increased activity of the Wnt pathway in IPF is confirmed by increased 
phosphorylation of LRP6 and GSK-3.     
4.5.3 Liver fibrosis 
Liver fibrosis represents chronic wound repair and is causally associated with persistent 
hepatic stellate cell (HSC) activation. Expression of Wnt and Fz genes is induced in HSC 
isolated from experimental cholestatic liver fibrosis, and Dkk-1 expression ameliorates this 
form of liver fibrosis in mice. These results suggest canonical Wnt signaling plays a role in 
liver fibrosis through activating HSC (Cheng et al, 2008). Moreover, both Wnt1 and Wnt10b 
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potently suppress adipocyte differentiation via its inhibition of the adipogenic transcription 
factors CCAAT/enhanced binding protein family (C/EBP) and peroxisome proliferator-
activated receptor-Ǆ (PPARǄ). The activated rat HSCs are shown to express higher levels of 
Wnt4, Wnt5, and Fz2 in culture and experimental liver fibrosis model .  
4.6 Other diseases  
4.6.1 Diabetes 
It is known that the canonical Wnt pathway is involved in the development and genesis of 
mouse pancreatic islets, pancreatic beta cell growth. The canonnial Wnt signaling is also 
associated with diabetes (Jin, 2008). Several components of this pathway play important 
roles in normal cholesterol metabolism and glucose-induced insulin secretion and the 
production of the incretin hormone glucagon-like peptide-1 (GLP-1). For example, 
polymorphisms in TCF7L2, also known as TCF-4, have by far the biggest effect on the risk of 
type 2 diabetes. The human LRP5 gene is mapped to within the IDDM4 region, which is 
linked to type 1 diabetes on chromosome 11q13, and polymorphisms in LRP5 have shown to 
be associated with obesity phenotypes, and missense mutations in LRP6 are shown to be 
associated with the risk of bone loss, early coronary disease and the metabolic syndrome. In 
addition, forkhead box transcription factor subgroup O (FOXO) and TCF proteins are able to 
compete for the limited pool of ǃ-catenin, and ageing will lead to increased FOXO-mediated 
gene transcription and reduce TCF-mediated gene transcription. Thus, these findings 
indicate that type 2 diabetes is an age-dependent disease.  
4.6.2 Obesity  
Obesity is linked to major adverse health outcomes such as insulin resistance and type 2 
diabetes. With obesity, adipose tissue mass expands and adipocyte (fat cell) size increases. As 
previously discussed, canonical Wnt signaling pathway is essential for adipogenesis and type 
2 diabetes. Thus, canonical Wnt signaling plays an important role in the genesis of obesity. 
4.6.3 Osteoporosis and Osteoarthritis (OA)  
Osteoporosis and osteoarthritis (OA) cause significant morbidity in the middle-age and 
elderly population. Bone tissue and chondrogenesis are involved in the pathogenesis of OA, 
which is characterized with subchondral sclerosis and the formation of osteophytic new 
bone. It is well known that the canonical Wnt pathway has emerged as an important 
regulator of chondrogenesis, bone development and remodeling. Thus, it is indicated that 
this Wnt pathway may be involved in the pathogenesis of OA (Velasco et al., 2010). For 
example, loss-of-function mutations of the LRP5 gene can result in osteoporosis, whereas 
activating mutations are associated with increased bone mass. It is reported that targeted 
deletion of the FrzB gene can increase the injury-associated loss of articular cartilage in mice, 
in association with increased cortical bone thickness and density. Recent work has found 
that expression of seven genes (BCL9, Fz5, Dvl2, EP300, FrzB, LRP5, and TCF7L1) is 
consistently upregulated both in tissue samples and in cell cultures from patients with knee 
osteoarthritis. These studies also demonstrate that three SNPs of the LRP5 gene and one in 
the LRP6 gene show marginally significant differences in allelic frequencies across the 
patient groups. 
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5. Conclusion and prospection  
The canonical Wnt signaling is widely known as one of the key pathways that are essential 
for the embryogenesis of vertebrates. In recent years, increasing lines of evidence have 
demonstrated that abnormal activivation of this pathway is closely associated with the 
development and progression of human diseases such as various tumors. Although 
investigations have provided new insights into the molecular mechanism underlying the 
roles and regulation of canonical Wnt signaling in animal models and patients, many critical 
questions remain to be answered. For example, it is largely unclear how the expression of 
components in this pathway is spatiotemporally controlled and secreted during embryonic 
development, what mechanisms are involved in the control of Wnt/-catenin activity by 
newly identified proteins, and what factors control the nuclear import of -catenin that is 
necessary for the expression of downstream genes. Since the functions of canonical Wnt 
signaling in the formation of animal organs such as liver and the development of some of 
human diseases are not well understood, it will be of great interest to investigate its effects 
on activity and regulation of key signaling molecules in developmental and pathological 
contexts. We firmly believe that a better understanding of canonical Wnt signaling 
regulation will have a broad impact on biology and medicine.  
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